Prof. C.J.A. Punt MD PhD publications

2021

• Hamers Patricia A. H., Elferink Marloes A. G., Stellato Rebecca K., Punt Cornelis J. A., May Anne M., Koopman Miriam, Vink Geraldine R. Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life data International journal of cancer. Journal international du cancer 2021;148 (2):296-306 [PubMed]
• Jongeneel Gabrielle, Greuter Marjolein J. E., van Erning Felice N., Twisk Jos W. R., Koopman Miriam, Punt Cornelis J. A., Vink Geraldine R., Coupé Veerle M. H. Longitudinal effects of adjuvant chemotherapy and related neuropathy on HU in stage II and III colon cancer patients: A prospective cohort study International journal of cancer. Journal international du cancer 2021 [PubMed]
• Bahadoer Renu R., Dijkstra Esmée A., van Etten Boudewijn, Marijnen Corrie A. M., Putter Hein, Kranenbarg Elma Meershoek-Klein, Roodvoets Annet G. H., Nagtegaal Iris D., Beets-Tan Regina G. H., Blomqvist Lennart K., Fokstuen Tone, ten Tije Albert J., Capdevila Jaume, Hendriks Mathijs P., Edhemovic Ibrahim, Cervantes Andrés, Nilsson Per J., Glimelius Bengt, van de Velde Cornelis J. H., Hospers Geke A. P., Østergaard L., Svendsen Jensen F., Pfeiffer P., Jensen K. E. J., Hendriks M. P., Schreurs W. H., Knol H. P., van der Vliet J. J., Tuynman J. B., Bruynzeel A. M. E., Kerver E. D., Festen S., van Leerdam M. E., Beets G. L., Dewit L. G. H., Punt C. J. A., Tanis P. J., Geijsen E. D., Nieboer P., Bleeker W. A., ten Tije A. J., Crolla R. M. P. H., van de Luijtgaarden A. C. M., Dekker J. W. T., Immink J. M., Jeurissen F. J. F., Marinelli A. W. K. S., Ceha H. M., van den Berg H., de Boer J. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial lancet oncology 2021;22 (1):29-42 [PubMed]
• Wensink G. Emerens, Elferink Marloes A. G., May Anne M., Mol Linda, Hamers Patricia A. H., Bakker Sandra D., Creemers Geert-Jan, de Groot Jan Willem B., de Klerk Gerty J., Haberkorn Brigitte C. M., Haringhuizen Annebeth W., Hoekstra Ronald, Hunting J. Cornelis B., Kerver Emile D., Mathijssen-van Stein Danielle, Polée Marco B., Pruijt Johannes F. M., Quarles van Ufford-Mannesse Patricia, Radema Sandra, Rietbroek Ronald C., Simkens Lieke H. J., Tanis Bea C., ten Bokkel Huinink Daan, Tjin-A-Ton Manuel L. R., Tromp-van Driel Cathrien S., Troost Monique M., van de Wouw Agnes J., van den Berkmortel Franchette W. P. J., van der Pas Anke J. M., van der Velden Ankie M. T., van Dijk Marjan A., van Dodewaard-de Jong Joyce M., van Druten Edith B., van Voorthuizen Theo, Jan Veldhuis Gerrit, Verheul Henk M. W., Vestjens Hanneke J. H. M. J., Vincent Jeroen, Kranenburg Onno W., Punt Cornelis J. A., Vink Geraldine R., Roodhart Jeanine M. L., Koopman Miriam Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era British journal of cancer 2021;124 (2):399-406 [PubMed]

2020

• Rovers Koen P., Bakkers Checca, van Erning Felice N., Burger Jacobus W. A., Nienhuijs Simon W., Simkens Geert A. A. M., Creemers Geert-Jan M., Hemmer Patrick H. J., Punt Cornelis J. A., Lemmens Valery E. P. P., Tanis Pieter J., de Hingh Ignace H. J. T. Adjuvant Systemic Chemotherapy vs Active Surveillance following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases JAMA oncology 2020;6 (8) [PubMed]
• Wesdorp Nina J., Hellingman Tessa, Jansma Elise P., van Waesberghe Jan-Hein T. M., Boellaard Ronald, Punt Cornelis J. A., Huiskens Joost, Kazemier Geert Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment European journal of nuclear medicine and molecular imaging 2020 [PubMed]
• Belkouz A., Wilmink J. W., Haj Mohammad N., Hagendoorn J., de Vos-Geelen J., Dejong C. H. C., Homs M. Y. V., Groot Koerkamp B., van Gulik T. M., van Oijen M. G. H., Punt C. J. A., Klümpen H. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials Critical reviews in oncology/hematology 2020;151 [PubMed]
• Boudewijns Steve, Bloemendal Martine, de Haas Nienke, Westdorp Harm, Bol Kalijn F., Schreibelt Gerty, Aarntzen Erik H. J. G., Lesterhuis W. Joost, Gorris Mark A. J., Croockewit Alexandra, van der Woude Lieke L., van Rossum Michelle M., Welzen Marieke, de Goede Anna, Hato Stanleyson V., van der Graaf Winette T. A., Punt Cornelis J. A., Koornstra Rutger H. T., Gerritsen Winald R., Figdor Carl G., de Vries I. Jolanda M. Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial Cancer immunology, immunotherapy 2020;69 (3):477-488 [PubMed]
• Netterberg Ida, Karlsson Mats O, Terstappen Leon W M M, Koopman Miriam, Punt Cornelis J A, Friberg Lena E Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework Clinical cancer research 2020;26 (18):4892-4900 [PubMed]
• Kilgallen Aoife B., Štibler Urška, Printezi Markella I., Putker Marrit, Punt Cornelis J. A., Sluijter Joost P. G., May Anne M., van Laake Linda W. Comparing conventional chemotherapy to chronomodulated chemotherapy for cancer treatment: Protocol for a systematic review JMIR research protocols 2020;9 (10) [PubMed]
• Bolhuis Karen, Kos Milan, van Oijen Martijn G. H., Swijnenburg Rutger-Jan, Punt Cornelis J. A. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review European journal of cancer (Oxford, England 2020;141:225-238 [PubMed]
• van 't Erve Iris, Greuter Marjolein J. E., Bolhuis Karen, Vessies Daan C. L., Leal Alessandro, Vink Geraldine R., van den Broek Daan, Velculescu Victor E., Punt Cornelis J. A., Meijer Gerrit A., Coupé Veerle M. H., Fijneman Remond J. A. Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal Cancer Journal of molecular diagnostics 2020;22 (12):1430-1437 [PubMed]
• Koopman Miriam, Punt Cornelis J. A. Duration of adjuvant treatment for patients with stage III colon cancer lancet oncology 2020;21 (12):1545-1547 [PubMed]
• Belkouz Ali, de Vos-Geelen Judith, Mathôt Ron A. A., Eskens Ferry A. L. M., van Gulik Thomas M., van Oijen Martijn G. H., Punt Cornelis J. A., Wilmink Johanna W., Klümpen Heinz-Josef Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial British journal of cancer 2020;122 (5):634-639 [PubMed]
• Belkouz Ali, Nooijen Lynn E., Riady Hanae, Franken Lotte C., van Oijen Martijn G. H., Punt Cornelis J. A., Erdmann Joris I., Klümpen Heinz-Josef Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review Cancer treatment reviews 2020;91 [PubMed]
• Nanou Afroditi, Mol Linda, Coumans Frank A. W., Koopman Miriam, Punt Cornelis J. A., Terstappen Leon W. M. M. Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer Cells 2020;9 (12) [PubMed]
• Jongeneel Gabrielle, Klausch Thomas, van Erning Felice N., Vink Geraldine R., Koopman Miriam, Punt Cornelis J. A., Greuter Marjolein J. E., Coupé Veerle M. H. Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data International journal of cancer. Journal international du cancer 2020;146 (11):2968-2978 [PubMed]
• Franken Mira D., de Hond Anne, Degeling Koen, Punt Cornelis J. A., Koopman Miriam, Uyl-de Groot Carin A., Versteegh Matthijs M., van Oijen Martijn G. H. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model Health and quality of life outcomes 2020;18 (1) [PubMed]
• Huiskens Joost, Kool Boudewijn R. J., Bakker Jean-Michel, Bruns Emma R. J., de Jonge Stijn W., Olthof Pim B., van Rosmalen Belle V., van Gulik Thomas M., Hooft Lotty, Punt Cornelis J. A. From registration to publication: A study on Dutch academic randomized controlled trials Research synthesis methods 2020;11 (2):218-226 [PubMed]
• Cohen Romain, Vernerey Dewi, Bellera Carine, Meurisse Aurélia, Henriques Julie, Paoletti Xavier, Rousseau Benoît, Alberts Steven, Aparicio Thomas, Boukovinas Ioannis, Gill Sharlene, Goldberg Richard M., Grothey Axel, Hamaguchi Tetsuya, Iveson Timothy, Kerr Rachel, Labianca Roberto, Lonardi Sara, Meyerhardt Jeffrey, Paul James, Punt Cornelis J. A., Saltz Leonard, Saunders Marck P., Schmoll Hans-Joachim, Shah Manish, Sobrero Alberto, Souglakos Ioannis, Taieb Julien, Takashima Atsuo, Wagner Anna Dorothea, Ychou Marc, Bonnetain Franck, Gourgou Sophie, Yoshino Takayuki, Yothers Greg, de Gramont Aimery, Shi Qian, André Thierry Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative European journal of cancer (Oxford, England 2020;130:63-71 [PubMed]
• Agasi-Idenburg Carla S., Zuilen Mieke Koning-van, Westerman Marjan J., Punt Cornelis J. A., Aaronson Neil K., Stuiver Martijn M. “I am busy surviving” - Views about physical exercise in older adults scheduled for colorectal cancer surgery Journal of geriatric oncology 2020;11 (3):444-450 [PubMed]
• Coebergh van den Braak R. R. J., ten Hoorn S., Sieuwerts A. M., Tuynman J. B., Smid M., Wilting S. M., Martens J. W. M., Punt C. J. A., Foekens J. A., Medema J. P., IJzermans J. N. M., Vermeulen L. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer BMC cancer 2020;20 (1):850 [PubMed]
• Kurk Sophie A., Peeters Petra H. M., Dorresteijn Bram, de Jong Pim A., Jourdan Marion, Creemers Geert-Jan M., Erdkamp Frans L. G., de Jongh Felix E., Kint Peter A. M., Poppema Boelo J., Radema Sandra A., Simkens Lieke H. J., Tanis Bea C., Tjin-A-Ton Manuel L. R., van der Velden Ankie, Punt Cornelis J. A., Koopman Miriam, May Anne M. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial Cancer medicine 2020;9 (3):1033-1043 [PubMed]
• Kwakman Johannes J. M., Elshot Yannick S., Punt Cornelis J. A., Koopman Miriam Management of cytotoxic chemotherapy-induced hand-foot syndrome Oncology Reviews 2020;14 (1):57-63 [PubMed]
• Jongeneel Gabrielle, Greuter Marjolein J. E., van Erning Felice N., Koopman Miriam, Vink Geraldine R., Punt Cornelis J. A., Coupé Veerle M. H. Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients Therapeutic advances in gastroenterology 2020;13 [PubMed]
• Jongeneel Gabrielle, Greuter Marjolein J. E., van Erning Felice N., Koopman Miriam, Medema Jan P., Kandimalla Raju, Goel Ajay, Bujanda Luis, Meijer Gerrit A., Fijneman Remond J. A., van Oijen Martijn G. H., Ijzermans Jan, Punt Cornelis J. A., Vink Geraldine R., Coupé Veerle M. H. Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN) European journal of health economics : HEPAC 2020;21 (7):1059-1073 [PubMed]
• Kok E. N. D., Havenga K., Tanis P. J., de Wilt J. H. W., Hagendoorn J., Peters F. P., Buijsen J., Rutten H. J. T., Kuhlmann K. F. D., Beets G. L., Aalbers A. G. J., Kok N. F. M., Ruers T. J. M., Kobus C. B. H. A., Siemons S. V., Grootscholten C., Dewit L. G. H., van den Berg J. G., Zavrakidis I., de Jong K. P., Hospers G. A. P., Karrenbeld A., Geijsen E. D., Punt C. J. A., Rutten H., Radema S., Intven M. P. W., Roodhart J. M. L., Holman F., Kapiteijn E., Melenhorst J., Cnossen J. S., Creemers G. -J. M. Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer British journal of surgery 2020;107 (5):537-545 [PubMed]
• André Thierry, Shiu Kai-Keen, Kim Tae Won, Jensen Benny Vittrup, Jensen Lars Henrik, Punt Cornelis, Smith Denis, Garcia-Carbonero Rocio, Benavides Manuel, Gibbs Peter, de la Fouchardiere Christelle, Rivera Fernando, Elez Elena, Bendell Johanna, le Dung T., Yoshino Takayuki, van Cutsem Eric, Yang Ping, Farooqui Mohammed Z. H., Marinello Patricia, Diaz Luis A. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer New England journal of medicine 2020;383 (23):2207-2218 [PubMed]
• Stroes Charlotte I., Schokker Sandor, Creemers Aafke, Molenaar Remco J., Hulshof Maarten C. C. M., van der Woude Stephanie O., Bennink Roel J., Mathôt Ron A. A., Krishnadath Kausilia K., Punt Cornelis J. A., Verhoeven Rob H. A., van Oijen Martijn G. H., Creemers Geert-Jan, Nieuwenhuijzen Grard A. P., van der Sangen Maurice J. C., Beerepoot Laurens V., Heisterkamp Joos, Los Maartje, Slingerland Marije, Cats Annemieke, Hospers Geke A. P., Bijlsma Maarten F., van Berge Henegouwen Mark I., Meijer Sybren L., van Laarhoven Hanneke W. M. Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study Journal of clinical oncology 2020;38 (5):462-471 [PubMed]
• Keikes Lotte, Koopman Miriam, Lemmens Valery E. P. P., VAN Oijen Martijn G. H., Punt Cornelis J. A. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study Anticancer research 2020;40 (8):4331-4341 [PubMed]
• Keikes Lotte, Koopman Miriam, Stuiver Martijn M., Lemmens Valery E. P. P., van Oijen Martijn G. H., Punt Cornelis J. A. Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study Acta oncologica (Stockholm, Sweden) 2020;59 (4):395-403 [PubMed]
• Versteijne Eva, Suker Mustafa, Groothuis Karin, Akkermans-Vogelaar Janine M., Besselink Marc G., Bonsing Bert A., Buijsen Jeroen, Busch Olivier R., Creemers Geert-Jan M., van Dam Ronald M., Eskens Ferry A. L. M., Festen Sebastiaan, de Groot Jan Willem B., Koerkamp Bas Groot, de Hingh Ignace H., Homs Marjolein Y. V., van Hooft Jeanin E., Kerver Emile D., Luelmo Saskia A. C., Neelis Karen J., Nuyttens Joost, Paardekooper Gabriel M. R. M., Patijn Gijs A., van der Sangen Maurice J. C., de Vos-Geelen Judith, Wilmink Johanna W., Zwinderman Aeilko H., Punt Cornelis J., van Eijck Casper H., van Tienhoven Geertjan Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial Journal of clinical oncology 2020;38 (16):1763-1773 [PubMed]
• Ubels Joske, Schaefers Tilman, Punt Cornelis, Guchelaar Henk-Jan, de Ridder Jeroen RAINFOREST: a random forest approach to predict treatment benefit in data from (failed) clinical drug trials Bioinformatics (Oxford, England) 2020;36 (2):i601-i609 [PubMed]
• Steins Anne, Klaassen Remy, Jacobs Igor, Schabel Matthias C., van Lier Monique G. J. T. B., Ebbing Eva A., Hectors Stefanie J., Tas Sander W., Maracle Chrissta X., Punt Cornelis J. A., Siebes Maria, Bergman Jacques J. G. H. M., Medema Jan Paul, Wilmink Johanna W., Mathot Ron A. A., Strijkers Gustav J., Bijlsma Maarten F., van Laarhoven Hanneke W. M. Rapid stromal remodeling by short-term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma Molecular oncology 2020;14 (4):704-720 [PubMed]
• van Tienhoven Geertjan, Versteijne Eva, Zwinderman Aeilko H., Punt Cornelis J., van Eijck Casper H. Reply to S. Shi et al and G.W. Peters et al Journal of clinical oncology 2020;38 (25):2945-2946 [PubMed]
• Derksen Jeroen W. G., Kurk Sophie A., Peeters Petra H. M., Dorresteijn Bram, Jourdan Marion, van der Velden Ankie M. T., Nieboer Peter, de Jong Robert S., Honkoop Aafke H., Punt Cornelis J. A., Koopman Miriam, May Anne M. The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE 2020;11 (4):919-928 [PubMed]
• van Cutsem E., Danielewicz I., Saunders M. P., Pfeiffer P., Argilés G., Borg C., Glynne-Jones R., Punt C. J. A., van de Wouw A. J., Fedyanin M., Stroyakovskiy D., Kroening H., Garcia-Alfonso P., Wasan H., Falcone A., Kanehisa A., Egorov A., Aubel P., Amellal N., Moiseenko V. Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study Annals of oncology 2020;31 (9):1160-1168 [PubMed]
• Nanou Afroditi, Miller M. Craig, Zeune Leonie L., de Wit Sanne, Punt Cornelis J. A., Groen Harry J. M., Hayes Daniel F., de Bono Johann S., Terstappen Leon W. M. M. Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival British journal of cancer 2020;122 (6):801-811 [PubMed]

2019

• Buisman F. E., Homs M. Y. V., Grünhagen D. J., Filipe W. F., Bennink R. J., Besselink M. G. H., Borel Rinkes I. H. M., Bruijnen R. C. G., Cercek A., D’Angelica M. I., van Delden O. M., Donswijk M. L., van Doorn L., Doornebosch P. G., Emmering J., Erdmann J. I., IJzerman N. S., Grootscholten C., Hagendoorn J., Kemeny N. E., Kingham T. P., Klompenhouwer E. G., Kok N. F. M., Koolen S., Kuhlmann K. F. D., Kuiper M. C., Lam M. G. E., Mathijssen R. H. J., Moelker A., Oomen-de Hoop E., Punt C. J. A., te Riele W. W., Roodhart J. M. L., Swijnenburg R. J., Prevoo W., Tanis P. J., Vermaas M., Versleijen M. W. J., Veuger F. P., Weterman M. J., Verhoef C., Groot Koerkamp B. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial BMC cancer 2019;19 (1):327 [PubMed]
• Klaver Charlotte E. L., Wisselink Daniel D., Punt Cornelis J. A., Snaebjornsson Petur, Crezee Johannes, Aalbers Arend G. J., Brandt Alexandra, Bremers Andre J. A., Burger Jacobus W. A., Fabry Hans F. J., Ferenschild Floris, Festen Sebastiaan, van Grevenstein Wilhelmina M. U., Hemmer Patrick H. J., de Hingh Ignace H. J. T., Kok Niels F. M., Musters Gijsbert D., Schoonderwoerd Lotte, Tuynman Jurriaan B., van de Ven Anthony W. H., van Westreenen Henderik L., Wiezer Marinus J., Zimmerman David D. E., van Zweeden Annette A., Dijkgraaf Marcel G. W., Tanis Pieter J., Andeweg Caroline S., Bastiaenen Vivian P., Bemelman Willem A., van der Bilt Jarmila D. W., Bloemen Johanne, den Boer Frank C., Boerma Djamila, ten Bokkel Huinink Daan, Brokelman Walter J. A., Cense Huib A., Consten Esther C. J., Creemers Geert-Jan, Crolla Rogier M. P. H., Dekker Jan-Willem T., Demelinne Jennifer, van Det Marc J., van Diepen Karin K., Diepeveen Marjolein, van Duyn Eino B., van den Ende Esther D., Evers Pauline, van Geloven Anna A. W., van der Harst Erwin, Heemskerk Jeroen, Heikens Joost T., Hess Daniel A., Inberg Bas, Jansen Jan, Kloppenberg Frank W. H., Kootstra Thomas J. M., Kortekaas R. T. J., Los Maartje, Madsen Eva V. E., van der Mijle H. C. J., Mol Linda, Neijenhuis Peter A., Nienhuijs Simon W., van den Nieuwenhof Loes, Peeters Koen C. M. J., Polle Sebastiaan W., Pon Jolien, Poortman Pieter, Radema Sandra A., van Ramshorst Bert, de Reuver Philip R., Rovers Koen P., Schmitz Roderick F., Sluiter Nina, Sommeijer Dirkje W., Sonneveld D. J. A., van Sprundel T. C., Veltkamp Sanne C., Vermaas Maarten, Verwaal Victor J., Wassenaar Emma, Wegdam Johannes A., de Wilt Johannes H. W., Westerterp Marinke, Wit Fennie, Witkamp Arjen J., van Woensdregt Karlijn, van der Zaag Edwin S., Zournas Mandy Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial lancet. Gastroenterology & hepatology 2019;4 (10):761-770 [PubMed]
• Dieleman E. M. T. , Stalpers Lukas, Burgers S. , Brandsma D., van Linde M. E. , de Vos F. Y. F. L., Punt C. J. A. , Rasch C. R. N. Bevacizumab bij symptomatische cerebrale radiatienecrose Nederlands tijdschrift voor oncologie 2019;16 (3):115-121
• Steins Anne, Ebbing Eva A., Creemers Aafke, van der Zalm Amber P., Jibodh Rajni A., Waasdorp Cynthia, Meijer Sybren L., van Delden Otto M., Krishnadath Kausilia K., Hulshof Maarten C. C. M., Bennink Roelof J., Punt Cornelis J. A., Medema Jan Paul, Bijlsma Maarten F., van Laarhoven Hanneke W. M. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma International journal of cancer. Journal international du cancer 2019;145 (10):2792-2803 [PubMed]
• Kwakman Johannes J.M., van Kruijsdijk Rob C.M., Elias Sjoerd G., Seymour Matthew T., Meade Angela M., Visseren Frank L.J., Punt Cornelis J.A., Koopman Miriam Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer Acta oncologica (Stockholm, Sweden) 2019;58 (3):326-333 [PubMed]
• Burzykowski Tomasz, Coart Elisabeth, Saad Everardo D., Shi Qian, Sommeijer Dirkje W., Bokemeyer Carsten, Díaz-Rubio Eduardo, Douillard Jean-Yves, Falcone Alfredo, Fuchs Charles S., Goldberg Richard M., Hecht J. Randolph, Hoff Paulo M., Hurwitz Herbert, Kabbinavar Fairooz F., Koopman Miriam, Maughan Timothy S., Punt Cornelis J. A., Saltz Leonard, Schmoll Hans-Joachim, Seymour Matthew T., Tebbutt Niall C., Tournigand Christophe, van Cutsem Eric, de Gramont Aimery, Zalcberg John R., Buyse Marc Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer JAMA network open 2019;2 (9):e1911750 [PubMed]
• Derksen Jeroen W G, Kurk Sophie A, Oskam Marieke J, Peeters Petra H M, Punt Cornelis J A, Koopman Miriam, May Anne M Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer JNCI cancer spectrum 2019;3 (2):pkz014 [PubMed]
• Cristiano Stephen, Leal Alessandro, Phallen Jillian, Fiksel Jacob, Adleff Vilmos, Bruhm Daniel C., Jensen Sarah Østrup, Medina Jamie E., Hruban Carolyn, White James R., Palsgrove Doreen N., Niknafs Noushin, Anagnostou Valsamo, Forde Patrick, Naidoo Jarushka, Marrone Kristen, Brahmer Julie, Woodward Brian D., Husain Hatim, van Rooijen Karlijn L., Ørntoft Mai-Britt Worm, Madsen Anders Husted, van de Velde Cornelis J. H., Verheij Marcel, Cats Annemieke, Punt Cornelis J. A., Vink Geraldine R., van Grieken Nicole C. T., Koopman Miriam, Fijneman Remond J. A., Johansen Julia S., Nielsen Hans J. rgen, Meijer Gerrit A., Andersen Claus Lindbjerg, Scharpf Robert B., Velculescu Victor E. Genome-wide cell-free DNA fragmentation in patients with cancer Nature 2019;570 (7761):385-389 [PubMed]
• Keikes Lotte, de Vos-Geelen Judith, de Groot Jan Willem B., Punt Cornelis J. A., Simkens Lieke H. J., Trajkovic-Vidakovic Marija, Portielje Johanneke E. A., Vos Allert H., Beerepoot Laurens V., Hunting Cornelis B., Koopman Miriam, van Oijen Martijn G. H. Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancer Patient education and counseling 2019;102 (7):1331-1335 [PubMed]
• Huiskens Joost Improvement in treatment of colorectal liver metastases and the conduct of clinical research 2019. 212p. ISBN 9789463805766. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Punt C. J. A. , van Gulik T. M.)
• Wasmann Karin A. T. G. M., Klaver Charlotte E. L., van der Bilt Jarmila D. W., van Dieren Susan, Nagtegaal Iris D., Punt Cornelis J. A., van Ramshorst Bert, Wolthuis Albert M., de Wilt Johannes H. W., D’hoore André, van Santvoort Hjalmar C., Tanis Pieter J. Laparoscopic surgery facilitates administration of adjuvant chemotherapy in locally advanced colon cancer: Propensity score analyses Cancer Management and Research 2019;11:7141-7157 [PubMed]
• ter Voert Edwin E. G. W., Heijmen Linda, van Asten Jack J. A., Wright Alan J., Nagtegaal Iris D., Punt Cornelis J. A., de Wilt Johannes H. W., van Laarhoven Hanneke W. M., Heerschap Arend Levels of choline-containing compounds in normal liver and liver metastases of colorectal cancer as recorded by 1H MRS NMR in biomedicine 2019;32 (1) [PubMed]
• Stijns Rutger C. H., de Graaf Eelco J. R., Punt Cornelis J. A., Nagtegaal Iris D., Nuyttens Joost J. M. E., van Meerten Esther, Tanis Pieter J., de Hingh Ignace H. J. T., van der Schelling George P., Acherman Yair, Leijtens Jeroen W. A., Bremers Andreas J. A., Beets Geerard L., Hoff Christiaan, Verhoef Cornelis, Marijnen Corrie A. M., de Wilt Johannes H. W. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study JAMA surgery 2019;154 (1):47-54 [PubMed]
• Huiskens Joost, Bolhuis Karen, Engelbrecht Marc R. W., de Jong Koert P., Kazemier Geert, Liem Mike S. L., Verhoef Cornelis, de Wilt Johannes H. W., Punt Cornelis J. A., van Gulik Thomas M., van Amerongen M. J., Dejong Cornelis H. C., Gerhards Michael F., Grunhagen Dirk, Heijmen Linda, Hermans John J., Keijser Astrid, Klaase Joost M., van Lienden Krijn P., Molenaar Quintus I., Patijn Gijs A., Rijken Arjen M., Ruers Theo M., Swijnenburg Rutger-Jan, van Tinteren Harm Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel Journal of the American College of Surgeons 2019;229 (6):523-532.e2 [PubMed]
• Rovers Koen P., Bakkers Checca, Simkens Geert A. A. M., Burger Jacobus W. A., Nienhuijs Simon W., Creemers Geert-Jan M., Thijs Anna M. J., Brandt-Kerkhof Alexandra R. M., Madsen Eva V. E., Ayez Ninos, de Boer Nadine L., van Meerten Esther, Tuynman Jurriaan B., Kusters Miranda, Sluiter Nina R., Verheul Henk M. W., van der Vliet Hans J., Wiezer Marinus J., Boerma Djamila, Wassenaar Emma C. E., Los Maartje, Hunting Cornelis B., Aalbers Arend G. J., Kok Niels F. M., Kuhlmann Koert F. D., Boot Henk, Chalabi Myriam, Kruijff Schelto, Been Lukas B., van Ginkel Robert J., de Groot Derk Jan A., Fehrmann Rudolf S. N., de Wilt Johannes H. W., Bremers Andreas J. A., de Reuver Philip R., Radema Sandra A., Herbschleb Karin H., van Grevenstein Wilhelmina M. U., Witkamp Arjen J., Koopman Miriam, Haj Mohammad Nadia, van Duyn Eino B., Mastboom Walter J. B., Mekenkamp Leonie J. M., Nederend Joost, Lahaye Max J., Snaebjornsson Petur, Verhoef Cornelis, van Laarhoven Hanneke W. M., Zwinderman Aeilko H., Bouma Jeanette M., Kranenburg Onno, van 't Erve Iris, Fijneman Remond J. A., Dijkgraaf Marcel G. W., Hemmer Patrick H. J., Punt Cornelis J. A., Tanis Pieter J., de Hingh Ignace H. J. T. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: Protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6) BMC cancer 2019;19 (1) [PubMed]
• Schokker Sandor, van der Woude Stephanie O., van Kleef Jessy Joy, van Zoen Daan J., van Oijen Martijn G. H., Mearadji Banafsche, Beenen Ludo F. M., Stroes Charlotte I., Waasdorp Cynthia, Jibodh R. Aarti, Creemers Aafke, Meijer Sybren L., Hooijer Gerrit K. J., Punt Cornelis J. A., Bijlsma Maarten F., van Laarhoven Hanneke W. M. Phase I Dose escalation study with expansion cohort of the addition of nab-paclitaxel to capecitabine and oxaliplatin (CapOx) as first-line treatment of metastatic esophagogastric adenocarcinoma (ACTION study) Cancers 2019;11 (6) [PubMed]
• Belkouz Ali, Labeur Tim A., Dierks Joeri, Dijk Frederike, van Oijen Martijn G. H., Verheij Joanne, van Gulik Thomas M., van de Vijver Marc J., Wilmink Hanneke, Punt Cornelis J. A., Klümpen Heinz-Josef Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis Critical reviews in oncology/hematology 2019;141:82-94 [PubMed]
• Kurk Sophie, Peeters Petra, Stellato Rebecca, Dorresteijn B., de Jong Pim, Jourdan Marion, Creemers Geert-Jan, Erdkamp Frans, de Jongh Felix, Kint Peter, Simkens Lieke, Tanis Bea, Tjin-A-Ton Manuel, van der Velden Ankie, Punt Cornelis, Koopman Miriam, May Anne Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE 2019;10 (4):803-813 [PubMed]
• Ebbing Eva A., van der Zalm Amber P., Steins Anne, Creemers Aafke, Hermsen Simone, Rentenaar Rosa, Klein Michelle, Waasdorp Cynthia, Hooijer Gerrit K. J., Meijer Sybren L., Krishnadath Kausilia K., Punt Cornelis J. A., van Berge Henegouwen Mark I., Gisbertz Suzanne S., van Delden Otto M., Hulshof Maarten C. C. M., Medema Jan Paul, van Laarhoven Hanneke W. M., Bijlsma Maarten F. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma Proceedings of the National Academy of Sciences of the United States of America 2019;116 (6):2237-2242 [PubMed]
• Agasi-Idenburg S. C., Punt C. J. A., Aaronson N. K., Stuiver M. M. The association between preoperative fatigue and instrumental activities in daily living with complications and length of hospital stay in patients undergoing colorectal surgery Aging clinical and experimental research 2019;32:257-264 [PubMed]
• Kurk Sophie A., Stellato Rebecca K., Peeters Petra H. M., Dorresteijn Bram, Jourdan Marion, Oskam Marieke J., Punt Cornelis J. A., Koopman Miriam, May Anne M. Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients The American journal of clinical nutrition 2019;110 (6):1395-1403 [PubMed]
• Kwakman Johannes J. M., van Werkhoven Erik, Simkens Lieke H. J., van Rooijen Johan M., van de Wouw Yes A. J., Tije Albert J. ten, Creemers Geert-Jan M., Hendriks Mathijs P., Los Maartje, van Alphen Robbert J., Polée Marco B., Muller Erik W., van der Velden Ankie M. T., van Voorthuizen Theo, Koopman Miriam, Mol Linda, Punt Cornelis J. A. Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group Clinical colorectal cancer 2019;18 (2):e229-e230 [PubMed]

2018

• Koch Christine, Schwing Anna M., Herrmann Eva, Borner Markus, Diaz-Rubio Eduardo, Dotan Efrat, Feliu Jaime, Okita Natsuko, Souglakos John, Arkenau Hendrik T., Porschen Rainer, Koopman Miriam, Punt Cornelis J. A., de Gramont Aimery, Tournigand Christophe, Zeuzem Stefan, Trojan Joerg Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: An individual patient data based meta-analysis Oncotarget 2018;9 (12):10272-10283 [PubMed]
• Engelhardt Ellen G., Révész Dóra, Tamminga Hans J., Punt Cornelis J. A., Koopman Mirjam, Onwuteaka-Philipsen Bregje D., Steyerberg Ewout W., Jansma Ilse P., de Vet Henrica C. W., Coupé Veerle M. H. Clinical Usefulness of Tools to Support Decision-making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic Review Clinical colorectal cancer 2018;17 (1):e1-e12 [PubMed]
• Goey Kaitlyn K. H., Sørbye Halfdan, Glimelius Bengt, Adams Richard A., André Thierry, Arnold Dirk, Berlin Jordan D., Bodoky György, de Gramont Aimery, Díaz-Rubio Eduardo, Eng Cathy, Falcone Alfredo, Grothey Axel, Heinemann Volker, Hochster Howard S., Kaplan Richard S., Kopetz Scott, Labianca Roberto, Lieu Christopher H., Meropol Neal J., Price Timothy J., Schilsky Richard L., Schmoll Hans-Joachim, Shacham-Shmueli Einat, Shi Qian, Sobrero Alberto F., Souglakos John, van Cutsem Eric, Zalcberg John, van Oijen Martijn G. H., Punt Cornelis J. A., Koopman Miriam Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group European journal of cancer (Oxford, England 2018;100:35-45 [PubMed]
• Smeets Dominiek, Miller Ian S., O’Connor Darran P., Das Sudipto, Moran Bruce, Boeckx Bram, Gaiser Timo, Betge Johannes, Barat Ana, Klinger Rut, van Grieken Nicole C. T., Cremolini Chiara, Prenen Hans, Mazzone Massimiliano, Depreeuw Jeroen, Bacon Orna, Fender Bozena, Brady Joseph, Hennessy Bryan T., McNamara Deborah A., Kay Elaine, Verheul Henk M., Maarten Neerincx, Gallagher William M., Murphy Verena, Prehn Jochen H. M., Koopman Miriam, Punt Cornelis J. A., Loupakis Fotios, Ebert Matthias P. A., Ylstra Bauke, Lambrechts Diether, Byrne Annette T. Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy Nature communications 2018;9 (1) [PubMed]
• Huiskens Joost, Olthof Pim B., van der Stok Eric P., Bais Thomas, van Lienden Krijn P., Moelker Adriaan, Krumeich Jan, Roumen Rudi M., Grünhagen Dirk J., Punt Cornelis J. A., van Amerongen Martin, de Wilt Johannes H. W., Verhoef Cornelis, van Gulik Thomas M. Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison European journal of surgical oncology 2018;44 (1):108-114 [PubMed]
• Noordman Bo Jan, Verdam Mathilde G. E., Lagarde Sjoerd M., Hulshof Maarten C. C. M., van Hagen Pieter, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R., ten Kate Fiebo J. W., Creemers Geert-Jan M., Punt Cornelis J. A., Plukker John Th M., Verheul Henk M. W., Spillenaar Bilgen Ernst J., van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., Steyerberg Ewout W., van der Gaast Ate, Sprangers Mirjam A. G., van Lanschot J. Jan B. Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial Journal of clinical oncology 2018;36 (3):268-+ [PubMed]
• Keikes Lotte, van Oijen Martijn G. H., Lemmens Valery E. P. P., Koopman Miriam, Punt Cornelis J. A. Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group Clinical colorectal cancer 2018;17 (1):58-64 [PubMed]
• Kwakman Johannes J. M., Vink G., Vestjens J. H., Beerepoot L. V., de Groot J. W., Jansen R. L., Opdam F. L., Boot H., Creemers G. J., van Rooijen J. M., Los M., Vulink A. J. E., Schut H., van Meerten E., Baars A., Hamberg P., Kapiteijn E., Sommeijer D. W., Punt C. J. A., Koopman M. Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands International journal of clinical oncology / Japan Society of Clinical Oncology 2018;23 (3):482-489 [PubMed]
• Baas Jara, Krens Lisanne, Bohringer Stefan, Mol Linda, Punt Cornelis, Guchelaar Henk-Jan, Gelderblom Hans Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab PLoS ONE 2018;13 (12) [PubMed]
• Kurk Sophie A., Peeters Petra H. M., Dorresteijn Bram, de Jong Pim A., Jourdan Marion, Kuijf Hugo J., Punt Cornelis J. A., Koopman Miriam, May Anne M. Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE 2018;9 (5):909-919 [PubMed]
• van Rooijen K. L., Kurk S. A., van der Kruijssen D. E. W., Elias S., May A. M., Cats A., Creemers G. J. M., Erdkamp F. L. G., Loosveld O. J., Rodenburg C. J., Tanis P. J., Vink G. R., de Wilt J. H. W., Punt C. J. A., Koopman M. Influence of primary tumour sidedness on survival after upfront primary tumour resection (PTR) in synchronous metastatic colon cancer (mCC) Annals of oncology 2018;29:viii177-viii178 [PubMed]
• Engelhardt Ellen G., Révész D. ra, Tamminga Hans J., Punt Cornelis J. A., Koopman Miriam, Onwuteaka-Philipsen Bregje D., Steyerberg Ewout W., de Vet Henrica C. W., Coupé Veerle M. H. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer BMC medical informatics and decision making 2018;18 (1) [PubMed]
• van Dijk Erik, Biesma Hedde D., Cordes Martijn, Smeets Dominiek, Neerincx Maarten, Das Sudipto, Eijk Paul P., Murphy Verena, Barat Anna, Bacon Orna, Prehn Jochen H. M., Betge Johannes, Gaiser Timo, Fender Bozena, Meijer Gerrit A., McNamara Deborah A., Klinger Rut, Koopman Miriam, Ebert Matthias P. A., Kay Elaine W., Hennessey Bryan T., Verheul Henk M. W., Gallagher William M., O’Connor Darran P., Punt Cornelis J. A., Loupakis Fotios, Lambrechts Diether, Byrne Annette T., van Grieken Nicole C. T., Ylstra Bauke Loss of chromosome 18q11.2-q12.1 is predictive for survival in patients with metastatic colorectal cancer treated with bevacizumab Journal of clinical oncology 2018;36 (20):2052-2060 [PubMed]
• Degeling Koen, Franken Mira D., May Anne M., van Oijen Martijn G. H., Koopman Miriam, Punt Cornelis J. A., IJzerman Maarten J., Koffijberg Hendrik Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients Cancer epidemiology 2018;57:60-67 [PubMed]
• Coebergh van den Braak R. R. J., van Rijssen L. B., van Kleef J. J., Vink G. R., Berbee M., van Berge Henegouwen M. I., Bloemendal H. J., Bruno M. J., Burgmans M. C., Busch O. R. C., Coene P. P. L. O., Coupé V. M. H., Dekker J. W. T., van Eijck C. H. J., Elferink M. A. G., Erdkamp F. L. G., van Grevenstein W. M. U., de Groot J. W. B., van Grieken N. C. T., de Hingh I. H. J. T., Hulshof M. C. C. M., Ijzermans J. N. M., Kwakkenbos L., Lemmens V. E. P. P., Los M., Meijer G. A., Molenaar I. Q., Nieuwenhuijzen G. A. P., de Noo M. E., van de Poll-Franse L. V., Punt C. J. A., Rietbroek R. C., Roeloffzen W. W. H., Rozema T., Ruurda J. P., van Sandick J. W., Schiphorst A. H. W., Schipper H., Siersema P. D., Slingerland M., Sommeijer D. W., Spaander M. C. W., Sprangers M. A. G., Stockmann H. B. A. C., Strijker M., van Tienhoven G., Timmermans L. M., Tjin-A-Ton M. L. R., van der Velden A. M. T., Verhaar M. J., Verkooijen H. M., Vles W. J., de Vos-Geelen J. M. P. G. M., Wilmink J. W., Zimmerman D. D. E., van Oijen M. G. H., Koopman M., Besselink M. G. H., van Laarhoven H. W. M. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative Acta oncologica (Stockholm, Sweden) 2018;57 (2):195-202 [PubMed]
• Simkens Lieke H. J. Optimisation of systemic treatment in metastatic colorectal cancer 2018. ISBN 9789463751353. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Punt C. J. A., Koopman M.)
• Kwakman Johannes J. M. Oral drugs in the treatment of metastatic colorectal cancer 2018. ISBN 9789492679550. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Punt C. J. A., Koopman M.)
• Knijn Nikki Pathways of dissemination in colorectal cancerNijmegen: Proefschrift AIO; 2018. 208p. ISBN 978-94-92896-64-3. [UvA Dissertations Online] Radboud University Nijmegen. (Supervisors: Nagtegaal I. D., Punt Cornelis J. A.)
• Sjoquist Katrin M., Renfro Lindsay A., Simes R. John, Tebbutt Niall C., Clarke Stephen, Seymour Matthew T., Adams Richard, Maughan Timothy S., Saltz Leonard, Goldberg Richard M., Schmoll Hans-Joachim, van Cutsem Eric, Douillard Jean-Yves, Hoff Paulo M., Hecht Joel Randolph, Tournigand Christophe, Punt Cornelis J. A., Koopman Miriam, Hurwitz Herbert, Heinemann Volker, Zalcberg John R. Personalizing survival predictions in advanced colorectal cancer: The ARCAD nomogram project Journal of the National Cancer Institute 2018;110 (6):638-648 [PubMed]
• Goey Kaitlyn K. H. Predicting treatment outcomes in metastatic colorectal cancer: heterogeneity in patient characteristics, treatment efficacy and molecular diagnosticsUtrecht: Gildeprint Drukkerijen - Enschede; 2018. 193p. ISBN 9789462338760. [UvA Dissertations Online] UMC Utrecht. (Supervisors: Koopman M., Punt C. J. A.; Co-supervisor: van Oijen M. G. H.)
• van Rooijen K. L., Shi Q., Goey K. K. H., Meyers J., Heinemann V., Diaz-Rubio E., Aranda E., Falcone A., Green E., de Gramont A., Sargent D. J., Punt C. J. A., Koopman M. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database European journal of cancer (Oxford, England 2018;91:99-106 [PubMed]
• Punt Cornelis J. A., Huiskens Joost, van Gulik Thomas, Engelbrecht Marc Pseudoprogression on bevacizumab treatment: tumor-dynamics in the modern era of systemic treatment for metastatic colorectal cancer Acta oncologica (Stockholm, Sweden) 2018;57 (5):681-682 [PubMed]
• Uyl-de Groot Carin A, van Rooijen Elisabeth M, Punt Cornelis J A, Pescott Chris P Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands Health economics 2018;8 (1):13 [PubMed]
• Goey Kaitlyn K. H., Mahmoud Remi, Sørbye Halfdan, Glimelius Bengt, Köhne Claus-Henning, Sargent Daniel J., Punt Cornelis J. A., van Oijen Martijn G. H., Koopman Miriam Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review European journal of cancer (Oxford, England 2018;96:115-124 [PubMed]
• Kurk S. A., Stellato R. K., Peeters P. H. M., Oskam M., Dorresteijn B. D., Jourdan M., Punt C. J. A., Koopman M., May A. M. Trajectory of skeletal muscle index (SMI) loss during palliative systemic treatment (Tx) predicts time to progression (TTP) in metastatic colorectal cancer (mCRC) patients Annals of oncology 2018;29:viii619 [PubMed]
• Trinh Anne, Lädrach Claudia, Dawson Heather E., ten Hoorn Sanne, Kuppen Peter J. K., Reimers Marlies S., Koopman Miriam, Punt Cornelis J. A., Lugli Alessandro, Vermeulen Louis, Zlobec Inti Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data British journal of cancer 2018;119 (10):1244-1251 [PubMed]
• Ebbing Eva A. What tumor cells cannot resist: Mechanisms of therapy resistance in esophageal adenocarcinoma 2018. ISBN 9789462958739. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Laarhoven H. W. M., Medema J. P.; Co-supervisors: Bijlsma M. F., Punt C. J. A.)

2017

• Rombouts Anouk J. M., Al-Najami Issam, Abbott Natalie L., Appelt Ane, Baatrup Gunnar, Bach Simon, Bhangu Aneel, Garm Spindler Karen-Lise, Gray Richard, Handley Kelly, Kaur Manjinder, Kerkhof Ellen, Kronborg Camilla Jensenius, Magill Laura, Marijnen Corrie A. M., Nagtegaal Iris D., Nyvang Lars, Peters Femke P., Pfeiffer Per, Punt Cornelis, Quirke Philip, Sebag-Montefiore David, teo Mark, West Nick, de Wilt Johannes H. W. Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study BMJ open 2017;7 (12):e019474 [PubMed]
• Kwakman Johannes J. M., Baars Arnold, van Zweeden Annette A., de Mol Pieter, Koopman Miriam, Kok Wouter E. M., Punt Cornelis J. A. Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm European journal of cancer (Oxford, England 2017;81:130-134 [PubMed]
• Renfro Lindsay A., Goldberg Richard M., Grothey Axel, Sobrero Alberto, Adams Richard, Seymour Matthew T., Heinemann Volker, Schmoll Hans-Joachim, Douillard Jean-Yves, Hurwitz Herbert, Fuchs Charles S., Diaz-Rubio Eduardo, Porschen Rainer, Tournigand Christophe, Chibaudel Benoist, Hoff Paulo M., Kabbinavar Fairooz F., Falcone Alfredo, Tebbutt Niall C., Punt Cornelis J. A., Hecht J. Randolph, Souglakos John, Bokemeyer Carsten, van Cutsem Eric, Saltz Leonard, de Gramont Aimery, Sargent Daniel J. Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database Journal of clinical oncology 2017;35 (17):1929-1937 [PubMed]
• Goey Kaitlyn K. H., Elias Sjoerd G., Hinke Axel, van Oijen Martijn G. H., Punt Cornelis J. A., Hegewisch-Becker Susanna, Arnold Dirk, Koopman Miriam Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials British journal of cancer 2017;117 (12):1768-1776 [PubMed]
• Klaver Charlotte E. L., Stam Roos, Sloothaak Didi A. M., Crezee Johannes, Bemelman Willem A., Punt Cornelis J. A., Tanis Pieter J. Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives Oncotarget 2017;8 (31):51200-51209 [PubMed]
• Agasi-Idenburg S. C., Thong M. S. Y., Punt C. J. A., Stuiver M. M., Aaronson N. K. Comparison of symptom clusters associated with fatigue in older and younger survivors of colorectal cancer Supportive care in cancer 2017;25 (2):625-632 [PubMed]
• Franken M. D., van Rooijen E. M., May A. M., Koffijberg H., van Tinteren H., Mol L., ten Tije A. J., Creemers G. J., van der Velden A. M. T., Tanis B. C., Uyl-de Groot C. A., Punt C. J. A., Koopman M., van Oijen M. G. H. Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer European journal of cancer (Oxford, England 2017;75:204-212 [PubMed]
• Bosch Linda J. W., Trooskens Geert, Snaebjornsson Petur, Coupé Veerle M. H., Mongera Sandra, Haan Josien C., Richman Susan D., Koopman Miriam, Tol Jolien, de Meyer Tim, Louwagie Joost, Dehaspe Luc, van Grieken Nicole C. T., Ylstra Bauke, Verheul Henk M. W., van Engeland Manon, Nagtegaal Iris D., Herman James G., Quirke Philip, Seymour Matthew T., Punt Cornelis J. A., van Criekinge Wim, Carvalho Beatriz, Meijer Gerrit A. Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer Oncotarget 2017;8 (38):63140-63154 [PubMed]
• Phallen Jillian, Sausen Mark, Adleff Vilmos, Leal Alessandro, Hruban Carolyn, White James, Anagnostou Valsamo, Fiksel Jacob, Cristiano Stephen, Papp Eniko, Speir Savannah, Reinert Thomas, Orntoft Mai-Britt Worm, Woodward Brian D., Murphy Derek, Parpart-Li Sonya, Riley David, Nesselbush Monica, Sengamalay Naomi, Georgiadis Andrew, Li Qing Kay, Madsen Mogens Rørbæk, Mortensen Frank Viborg, Huiskens Joost, Punt Cornelis, van Grieken Nicole, Fijneman Remond, Meijer Gerrit, Husain Hatim, Scharpf Robert B., Diaz Luis A., Jones Siân, Angiuoli Sam, Ørntoft Torben, Nielsen Hans Jørgen, Andersen Claus Lindbjerg, Velculescu Victor E. Direct detection of early-stage cancers using circulating tumor DNA Science translational medicine 2017;9 (403):eeaan2415 [PubMed]
• Hato Stanleyson V., Figdor Carl G., Takahashi Susumu, Pen Anja E., Halilovic Altuna, Bol Kalijn F., Vasaturo Angela, Inoue Yukie, de Haas Nienke, Verweij Dagmar, van Herpen Carla M. L., Kaanders Johannes H., van Krieken Johan H. J. M., van Laarhoven Hanneke W. M., Hooijer Gerrit K. J., Punt Cornelis J. A., Asai Akira, de Vries I. Jolanda M., Joost Lesterhuis W. Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity Oncotarget 2017;8 (33):54434-54443 [PubMed]
• Engelhardt Ellen G., Pieterse Arwen H., Han Paul K. J., van Duijn-Bakker Nanny, Cluitmans Frans, Maartense Ed, Bos Monique M. E. M., Weijl Nir I., Punt Cornelis J. A., Quarles van Ufford-Mannesse Patricia, Sleeboom Harm, Portielje Johanneke E. A., van der Hoeven Koos J. M., Woei-A-Jin F. J. Sherida, Kroep Judith R., de Haes Hanneke C. J. M., Smets Ellen M. A., Stiggelbout Anne M. Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer Medical decision making 2017;37 (3):179-192 [PubMed]
• Lamkaddem M., Elferink M. A. G., Seeleman M. C., Dekker E., Punt C. J. A., Visser O., Essink-Bot M. L. Ethnic differences in colon cancer care in the Netherlands: a nationwide registry-based study BMC cancer 2017;17 (1):312 [PubMed]
• Keikes Lotte, Koopman Miriam, Tanis Pieter J., Lemmens Valery E. P. P., Punt Cornelis J. A., van Oijen Martijn G. H. Evaluating the scientific basis of quality indicators in colorectal cancer care: A systematic review European journal of cancer (Oxford, England 2017;86:166-177 [PubMed]
• Punt Cornelis J. A., Koopman Miriam, Vermeulen Louis From tumour heterogeneity to advances in precision treatment of colorectal cancer Nature reviews. Clinical oncology 2017;14 (4):235-246 [PubMed]
• Bonnetain F., Borg C., Adams R. R., Ajani J. A., Benson A., Bleiberg H., Chibaudel B., Diaz-Rubio E., Douillard J. Y., Fuchs C. S., Giantonio B. J., Goldberg R., Heinemann V., Koopman M., Labianca R., Larsen A. K., Maughan T., Mitchell E., Peeters M., Punt C. J. A., Schmoll H. J., Tournigand C., de Gramont A. How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials Annals of oncology 2017;28 (9):2077-2085 [PubMed]
• Kwakman Johannes J. M., Simkens Lieke H. J., Mol Linda, Kok Wouter E. M., Koopman Miriam, Punt Cornelis J. A. Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group European journal of cancer (Oxford, England 2017;76:93-99 [PubMed]
• Ruers Theo, van Coevorden Frits, Punt Cornelis J. A., Pierie Jean-Pierre E. N., Borel-Rinkes Inne, Ledermann Jonathan A., Poston Graeme, Bechstein Wolf, Lentz Marie-Ange, Mauer Murielle, Folprecht Gunnar, van Cutsem Eric, Ducreux Michel, Nordlinger Bernard Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial Journal of the National Cancer Institute 2017;109 (9):djx015 [PubMed]
• Goey K. K. H., Elias S. G., van Tinteren H., Laclé M. M., Willems S. M., Offerhaus G. J. A., de Leng W. W. J., Strengman E., ten Tije A. J., Creemers G.-J. M., van der Velden A., de Jongh F. E., Erdkamp F. L. G., Tanis B. C., Punt C. J. A., Koopman M. Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study Annals of oncology 2017;28 (9):2128-2134 [PubMed]
• Rovers Koen P., Simkens Geert A., Punt Cornelis J., van Dieren Susan, Tanis Pieter J., de Hingh Ignace H. Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review Critical reviews in oncology/hematology 2017;114:53-62 [PubMed]
• Trinh Anne, Trumpi Kari, de Sousa E Melo Felipe, Wang Xin, de Jong Joan H., Fessler Evelyn, Kuppen Peter J. K., Reimers Marlies S., Swets Marloes, Koopman Miriam, Nagtegaal Iris D., Jansen Marnix, Hooijer Gerrit K. J., Offerhaus George J. A., Kranenburg Onno, Punt Cornelis J., Medema Jan Paul, Markowetz Florian, Vermeulen Louis Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry Clinical cancer research 2017;23 (2):387-398 [PubMed]
• Mol Linda Quality aspects of Dutch colorectal cancer trials 2017. 109p. ISBN 9789402806717. [UvA Dissertations Online] Radboud Universiteit: Faculteit Geneeskunde. (Supervisor: Punt C. J. A.; Co-supervisors: Koopman M., Ottevanger P. O.)
• Versteijne Eva, Lens Eelco, van der Horst Astrid, Bel Arjan, Visser Jorrit, Punt Cornelis J. A., Suker Mustafa, van Eijck Casper H. J., van Tienhoven Geertjan Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run Qualitätssicherung in der PREOPANC-Studie (2012-003181-40) für die präoperative Radiochemotherapie beim Pankreaskarzinom : Der „dummy run“ Strahlentherapie und Onkologie 2017;193 (8):630-638 [PubMed]
• Kwakman J. J. M., Simkens L. H. J., van Rooijen J. M., van de Wouw A. J., ten Tije A. J., Creemers G. J. M., Hendriks M. P., Los M., van Alphen R. J., Polée M. B., Muller E. W., van der Velden A. M. T., van Voorthuizen T., Koopman M., Mol L., van Werkhoven E., Punt C. J. A. Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group Annals of oncology 2017;28 (6):1288-1293 [PubMed]
• 't Lam-Boer J., van der Stok E. P., Huiskens J., Verhoeven R. H. A., Punt C. J. A., Elferink M. A. G., de Wilt J. H., Verhoef C., Dejong C. H. C., Grunhagen D., van Gulik T. M., de Jong K. P., Kazemier G., Molenaar I. Q., Ruers T. M. Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the Netherlands European journal of cancer (Oxford, England 2017;71:109-116 [PubMed]
• Olthof Pim B., Huiskens Joost, Wicherts Dennis A., Huespe Pablo E., Ardiles Victoria, Robles-Campos Ricardo, Adam René, Linecker Michael, Clavien Pierre-Alain, Koopman Miriam, Verhoef Cornelis, Punt Cornelis J. A., van Gulik Thomas M., de Santibanes Eduardo Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case-matched comparison with palliative systemic therapy Surgery 2017;161 (4):909-919 [PubMed]
• Rovers Koen P., Simkens Geert A., Vissers Pauline A., Lemmens Valery E., Verwaal Victor J., Bremers Andre J., Wiezer Marinus J., Burger Jacobus W., Hemmer Patrick H., Boot Henk, van Grevenstein Wilhelmina M., Meijerink Wilhelmus J., Aalbers Arend G., Punt Cornelis J., Tanis Pieter J., de Hingh Ignace H. Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study European journal of cancer (Oxford, England 2017;75:132-140 [PubMed]
• Keikes Lotte, Medlock Stephanie, van de Berg Daniël J,, Zhang Shuxin, Guicherit Onno R., Punt Cornelis J. A., van Oijen Martijn G. H. The first steps in the evaluation of a "black-box" decision support tool: a protocol and feasibility study for the evaluation of Watson for Oncology Journal of clinical and translational research 2017;3 (S3):411-423
• Buyse Marc, Squifflet Pierre, Coart Elisabeth, Quinaux Emmanuel, Punt Cornelis J. A., Saad Everardo D. The impact of data errors on the outcome of randomized clinical trials Clinical trials (London, England) 2017;14 (5):499-506 [PubMed]
• Kwakman J. J. M., Baars A., Boot H., Pruijt J. F. M., Winther S. B., Pfeiffer P., Punt C. J. A. Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients Acta oncologica (Stockholm, Sweden) 2017;56 (7):1023-1026 [PubMed]
• Tanis Pieter J., Beets-Tan Regina G. H., Marijnen Corrie A. M., Nagtegaal Iris D., Punt Cornelis J. A. Tumoren van dunne en dikke darmin: C .J. H. van de Velde, W. T. A. van der Graaf, J. H. J. M. van Krieken, C. A. M. Marijnen, editors. Leerboek oncologie. Bohn Stafleu Van Loghum; 2017. p. 361-377, ISBN 9789036804417

2016

• Boudewijns Steve, Bol Kalijn F., Schreibelt Gerty, Westdorp Harm, Textor Johannes C., van Rossum Michelle M., Scharenborg Nicole M., de Boer Annemiek J., van de Rakt Mandy W. M. M., Pots Jeanne M., van Oorschot Tom G. M., Duiveman-de Boer Tjitske, Olde Nordkamp Michel A., van Meeteren Wilmy S. E. C., van der Graaf Winette T. A., Bonenkamp Johannes J., de Wilt Johannes H. W., Aarntzen Erik H. J. G., Punt Cornelis J. A., Gerritsen Winald R., Figdor Carl G., de Vries I. Jolanda M. Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients Oncoimmunology 2016;5 (7):e1191732 [PubMed]
• Bol Kalijn F., van den Bosch Thomas, Schreibelt Gerty, Mensink Hanneke W., Keunen Jan E. E., Kiliç Emine, Japing Wouter J., Geul Kaspar W., Westdorp Harm, Boudewijns Steve, Croockewit Sandra A. J., van Rossum Michelle M., de Goede Anna L., Naus Nicole C., van der Graaf Winette T. A., Gerritsen Winald R., de Klein Annelies, Punt Cornelis J. A., Figdor Carl G., Cohen Victoria M., Paridaens Dion, de Vries I. Jolanda M. Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma Ophthalmology 2016;123 (10):2265-2267 [PubMed]
• Borstlap W. A. A., Tanis P. J., Koedam T. W. A., Marijnen C. A. M., Cunningham C., Dekker E., van Leerdam M. E., Meijer G., van Grieken N., Nagtegaal I. D., Punt C. J. A., Dijkgraaf M. G. W., de Wilt J. H., Beets G., de Graaf E. J., van Geloven A. A. W., Gerhards M. F., van Westreenen H. L., van de Ven A. W. H., van Duijvendijk P., de Hingh I. H. J. T., Leijtens J. W. A., Sietses C., Spillenaar-Bilgen E. J., Vuylsteke R. J. C. L. M., Hoff C., Burger J. W. A., van Grevenstein W. M. U., Pronk A., Bosker R. J. I., Prins H., Smits A. B., Bruin S., Zimmerman D. D., Stassen L. P. S., Dunker M. S., Westerterp M., Coene P. P., Stoot J., Bemelman W. A., Tuynman J. B. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer BMC cancer 2016;16 (1):513 [PubMed]
• Renfro Lindsay A., Loupakis Fotios, Adams Richard A., Seymour Matthew T., Heinemann Volker, Schmoll Hans-Joachim, Douillard Jean-Yves, Hurwitz Herbert, Fuchs Charles S., Diaz-Rubio Eduardo, Porschen Rainer, Tournigand Christophe, Chibaudel Benoist, Falcone Alfredo, Tebbutt Niall C., Punt Cornelis J. A., Hecht J. Randolph, Bokemeyer Carsten, van Cutsem Eric, Goldberg Richard M., Saltz Leonard B., de Gramont Aimery, Sargent Daniel J., Lenz Heinz-Josef Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database Journal of clinical oncology 2016;34 (2):144-+ [PubMed]
• Razenberg Lieke G. E. M., Lemmens Valery E. P. P., Verwaal Victor J., Punt Cornelis J. A., Tanis Pieter J., Creemers Geert-Jan, de Hingh Ignace H. J. T. Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study European journal of cancer (Oxford, England 2016;65:113-120 [PubMed]
• Goey K., Elias S., Hinke A., van Oijen M., Punt C., Becker S. Hegewisch, Arnold D., Koopman M. Clinical factors influencing outcome in metastatic colorectal cancer (mCRC) patients treated with fluoropyrimidine and bevacizumab (FP + Bev) maintenance treatment (Tx) vs observation: A pooled analysis of the phase 3 CAIRO3 and AIO 0207 trials Annals of oncology 2016;27:vi153
• van Grieken N. C., Cordes M., Verheul H. M., Neerincx M., Punt C., Koopman M., Meijer G. A., Murphy V., Barat A., Betge J., Ebert M., Gaiser T., Fender B., Klinger R., Das S., Smeets D., O'Connor D., Lambrechts D., Byrne A. T., Ylstra B. Copy number alterations as predictive biomarkers for response to bevacizumab in metastatic colorectal cancer Annals of oncology 2016;27:vi15
• Schreibelt Gerty, Bol Kalijn F., Westdorp Harm, Wimmers Florian, Aarntzen Erik H. J. G., Duiveman-de Boer Tjitske, van de Rakt Mandy W. M. M., Scharenborg Nicole M., de Boer Annemiek J., Pots Jeanette M., Olde Nordkamp Michel A. M., van Oorschot Tom G. M., tel Jurjen, Winkels Gregor, Petry Katja, Blokx Willeke A. M., van Rossum Michelle M., Welzen Marieke E. B., Mus Roel D. M., Croockewit Sandra A. J., Koornstra Rutger H. T., Jacobs Joannes F. M., Kelderman Sander, Blank Christian U., Gerritsen Winald R., Punt Cornelis J. A., Figdor Carl G., de Vries I. Jolanda M. Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells Clinical cancer research 2016;22 (9):2155-2166 [PubMed]
• van Cutsem E., Cervantes A., Adam R., Sobrero A., van Krieken J. H., Aderka D., Aranda Aguilar E., Bardelli A., Benson A., Bodoky G., Ciardiello F., D'Hoore A., Diaz-Rubio E., Douillard J.-Y., Ducreux M., Falcone A., Grothey A., Gruenberger T., Haustermans K., Heinemann V., Hoff P., Köhne C.-H., Labianca R., Laurent-Puig P., Ma B., Maughan T., Muro K., Normanno N., Österlund P., Oyen W. J. G., Papamichael D., Pentheroudakis G., Pfeiffer P., Price T. J., Punt C., Ricke J., Roth A., Salazar R., Scheithauer W., Schmoll H. J., Tabernero J., Taïeb J., Tejpar S., Wasan H., Yoshino T., Zaanan A., Arnold D. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Annals of oncology 2016;27 (8):1386-1422 [PubMed]
• van Staveren Maurice C., van Kuilenburg Andre B. P., Guchelaar Henk-Jan, Meijer Judith, Punt Cornelis J. A., de Jong Robert S., Gelderblom Hans, Maring Jan Gerard Evaluation of an oral uracil loading test to identify DPD-deficient patients using a limited sampling strategy British journal of clinical pharmacology 2016;81 (3):553-561 [PubMed]
• Kurk S. A., Peeters P. H. M., Dorresteijn B., Jourdan M., Kuijf H. J., Punt C., Koopman M., May A. M. Evolution of skeletal muscle mass (SMM) during palliative systemic treatment in metastatic colorectal cancer (mCRC) patients participating in the randomized phase 3 CAIRO3 study Annals of oncology 2016;27:vi199
• Bol Kalijn F., Aarntzen Erik H. J. G., In 't Hout Florentien E. M., Schreibelt Gerty, Creemers Jeroen H. A., Lesterhuis W. Joost, Gerritsen Winald R., Grunhagen Dirk J., Verhoef Cornelis, Punt Cornelis J. A., Bonenkamp Johannes J., de Wilt Johannes H. W., Figdor Carl G., de Vries I. Jolanda M. Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination Oncoimmunology 2016;5 (1):e1057673 [PubMed]
• Boudewijns Steve, Westdorp Harm, Koornstra Rutger H. T., Aarntzen Erik H. J. G., Schreibelt Gerty, Creemers Jeroen H. A., Punt Cornelis J. A., Figdor Carl G., de Vries I. Jolanda M., Gerritsen Winald R., Bol Kalijn F. Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients Journal of immunotherapy (Hagerstown, Md. 2016;39 (6):241-248 [PubMed]
• Knijn Nikki, van Erning Felice N., Overbeek Lucy I. H., Punt Cornelis J. A., Lemmens Valery E. P. P., Hugen Niek, Nagtegaal Iris D. Limited effect of lymph node status on the metastatic pattern in colorectal cancer Oncotarget 2016;7 (22):31699-31707 [PubMed]
• van der Stok E. P., Huiskens J., Hemmes B., Grünhagen D. J., van Gulik T. M., Verhoef C., Punt C. J. A. Lokale toestemmingsprocedures zetten een rem op RCT's Nederlands tijdschrift voor geneeskunde 2016;160:D148 [PubMed]
• Eggermont Alexander M. M., Suciu Stefan, Rutkowski Piotr, Kruit Willem H., Punt Cornelis J., Dummer Reinhard, Salès François, Keilholz Ulrich, de Schaetzen Gaetan, Testori Alessandro Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity European journal of cancer (Oxford, England 2016;55:111-121 [PubMed]
• de Ridder Jannemarie A. M., van der Stok Eric P., Mekenkamp Leonie J., Wiering Bastiaan, Koopman Miriam, Punt Cornelis J. A., Verhoef Cornelis, de Wilt Johannes H. Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resection European journal of cancer (Oxford, England 2016;59:13-21 [PubMed]
• Kwakman J. J. M., Punt C. J. A. Oral drugs in the treatment of metastatic colorectal cancer Expert opinion on pharmacotherapy 2016;17 (10):1351-1361 [PubMed]
• Versteijne Eva, van Eijck Casper H. J., Punt Cornelis J. A., Suker Mustafa, Zwinderman Aeilko H., Dohmen Miriam A. C., Groothuis Karin B. C., Busch Oliver R. C., Besselink Marc G. H., de Hingh Ignace H. J. T., ten Tije Albert J., Patijn Gijs A., Bonsing Bert A., de Vos-Geelen Judith, Klaase Joost M., Festen Sebastiaan, Boerma Djamila, Erdmann Joris I., Molenaar I. Quintus, van der Harst Erwin, van der Kolk Marion B., Rasch Coen R. N., van Tienhoven Geertjan Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial Trials 2016;17 (1):127 [PubMed]
• Franko Jan, Shi Qian, Meyers Jeffrey P., Maughan Timothy S., Adams Richard A., Seymour Matthew T., Saltz Leonard, Punt Cornelis J. A., Koopman Miriam, Tournigand Christophe, Tebbutt Niall C., Diaz-Rubio Eduardo, Souglakos John, Falcone Alfredo, Chibaudel Benoist, Heinemann Volker, Moen Joseph, de Gramont Aimery, Sargent Daniel J., Grothey Axel Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database lancet oncology 2016;17 (12):1709-1719 [PubMed]
• de Cuba E. M. V., Snaebjornsson P., Heideman D. A. M., van Grieken N. C. T., Bosch L. J. W., Fijneman R. J. A., Belt E., Bril H., Stockmann H. B. A. C., Hooijberg E., Punt C. J. A., Koopman M., Nagtegaal I. D., Coupé V. H. M., Carvalho B., Meijer G. A. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers International journal of cancer. Journal international du cancer 2016;138 (5):1139-1145 [PubMed]
• Bol Kalijn F., Aarntzen Erik H. J. G., Pots Jeanette M., Olde Nordkamp Michel A. M., van de Rakt Mandy W. M. M., Scharenborg Nicole M., de Boer Annemiek J., van Oorschot Tom G. M., Croockewit Sandra A. J., Blokx Willeke A. M., Oyen Wim J. G., Boerman Otto C., Mus Roel D. M., van Rossum Michelle M., van der Graaf Chantal A. A., Punt Cornelis J. A., Adema Gosse J., Figdor Carl G., de Vries I. Jolanda M., Schreibelt Gerty Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity Cancer immunology, immunotherapy 2016;65 (3):327-339 [PubMed]
• Burbach J. P. M., Kurk S. A., Coebergh van den Braak R. R. J., Dik V. K., May A. M., Meijer G. A., Punt C. J. A., Vink G. R., Los M., Hoogerbrugge N., Huijgens P. C., Ijzermans J. N. M., Kuipers E. J., de Noo M. E., Pennings J. P., van der Velden A. M. T., Verhoef C., Siersema P. D., van Oijen M. G. H., Verkooijen H. M., Koopman M. Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research Acta oncologica (Stockholm, Sweden) 2016;55 (11):1273-1280 [PubMed]
• ter Voert Edwin E. G. W., Heijmen Linda, Punt Cornelis J. A., de Wilt Johannes H. W., van Laarhoven Hanneke W. M., Heerschap Arend Reduced respiratory motion artifacts using structural similarity in fast 2D dynamic contrast enhanced MRI of liver lesions NMR in biomedicine 2016;29 (11):1526-1535 [PubMed]
• van Erning F. N., Vissers P. A. J., Punt C. J. A., Lemmens V. E. P. P. RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up Supportive care in cancer 2016;24 (10):4079-4080 [PubMed]
• Goey Kaitlyn K. H., 't Lam-Boer Jorine, de Wilt Johannes H. W., Punt Cornelis J. A., van Oijen Martijn G. H., Koopman Miriam Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review European journal of cancer (Oxford, England 2016;69:166-177 [PubMed]
• Vasaturo Angela, Halilovic Altuna, Bol Kalijn F., Verweij Dagmar I., Blokx Willeke A. M., Punt Cornelis J. A., Groenen Patricia J. T. A., van Krieken J. Han J. M., Textor Johannes, de Vries I. Jolanda M., Figdor Carl G. T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines Cancer research 2016;76 (12):3496-3506 [PubMed]
• Mol L., Ottevanger P. B., Koopman M., Punt C. J. A. The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients European journal of cancer (Oxford, England 2016;66:138-143 [PubMed]
• Price Timothy J., Thavaneswaran Subotheni, Burge Matthew, Segelov Eva, Haller Daniel G., Punt Cornelis Ja, Arnold Dirk, Karapetis Christos S., Tebbutt Niall C., Pavlakis Nick, Gibbs Peter, Shapiro Jeremy D. Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015 Expert review of anticancer therapy 2016;16 (5):557-571 [PubMed]
• Mulder Sasja F. Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors in cancerNijmegen: J Ontwerp; 2016. 159p. ISBN 9789064649585. [UvA Dissertations Online] Radboud University Nijmegen: Medische Oncologie. (Supervisors: Punt C. J. A., Vissers K. C. P.; Co-supervisor: van Herpen C. M. L.)
• Bosch Linda J. W., Luo Yanxin, Lao Victoria V., Snaebjornsson Petur, Trooskens Geert, Vlassenbroeck Ilse, Mongera Sandra, Tang Weiliang, Welcsh Piri, Herman James G., Koopman Miriam, Nagtegaal Iris D., Punt Cornelis J. A., van Criekinge Wim, Meijer Gerrit A., Monnat Raymond J., Carvalho Beatriz, Grady William M. WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy Clinical cancer research 2016;22 (18):4612-4622 [PubMed]

2015

• Trumpi K., Emmink B. L., Prins A. M., van Oijen M. G. H., van Diest P. J., Punt C. J. A., Koopman M., Kranenburg O., Borel Rinkes I. H. M. ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer Journal of Cancer 2015;6 (11):1079-1086 [PubMed]
• Breugom A. J., van Gijn W., Muller E. W., Berglund Å, van den Broek C. B. M., Fokstuen T., Gelderblom H., Kapiteijn E., Leer J. W. H., Marijnen C. A. M., Martijn H., Meershoek-Klein Kranenbarg E., Nagtegaal I. D., Påhlman L., Punt C. J. A., Putter H., Roodvoets A. G. H., Rutten H. J. T., Steup W. H., Glimelius B., van de Velde C. J. H. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial Annals of oncology 2015;26 (4):696-701 [PubMed]
• Klaver Charlotte E. L., Musters Gijsbert D., Bemelman Willem A., Punt Cornelis J. A., Verwaal Victor J., Dijkgraaf Marcel G. W., Aalbers Arend G. J., van der Bilt Jarmila D. W., Boerma Djamila, Bremers Andre J. A., Burger Jacobus W. A., Buskens Christianne J., Evers Pauline, van Ginkel Robert J., van Grevenstein Wilhelmina M. U., Hemmer Patrick H. J., de Hingh Ignace H. J. T., Lammers Laureen A., van Leeuwen Barbara L., Meijerink Wilhelmus J. H. J., Nienhuijs Simon W., Pon Jolien, Radema Sandra A., van Ramshorst Bert, Snaebjornsson Petur, Tuynman Jurriaan B., te Velde Elisabeth A., Wiezer Marinus J., de Wilt Johannes H. W., Tanis Pieter J. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial BMC cancer 2015;15 (1):428 [PubMed]
• Peeters Marc, Oliner Kelly S., Price Timothy J., Cervantes Andrés, Sobrero Alberto F., Ducreux Michel, Hotko Yevhen, André Thierry, Chan Emily, Lordick Florian, Punt Cornelis J. A., Strickland Andrew H., Wilson Gregory, Ciuleanu Tudor E., Roman Laslo, van Cutsem Eric, He Pei, Yu Hua, Koukakis Reija, Terwey Jan-Henrik, Jung Andre S., Sidhu Roger, Patterson Scott D. Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer Clinical cancer research 2015;21 (24):5469-5479 [PubMed]
• Verseveld M., de Graaf E. J. R., Verhoef C., van Meerten E., Punt C. J. A., de Hingh I. H. J. T., Nagtegaal I. D., Nuyttens J. J. M. E., Marijnen C. A. M., de Wilt J. H. W., Tanis P. J., Bökkerink G. M. J., Rütten H., Doornebosch P. G., Derksen E. J., Dwarkasing R. S., Cats A., M Tollenaar R. A. E., Rutten H. J. T., Leijtens J. W. A., van der Schelling G. P., ten Tije A. J., Lammering G., Beets G. L., Aufenacker T. J., Pronk A., Manusama E. R., Hoff C., Bremers A. J. A. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study) British journal of surgery 2015;102 (7):853-860 [PubMed]
• Meulendijks Didier, Henricks Linda M., Sonke Gabe S., Deenen Maarten J., Froehlich Tanja K., Amstutz Ursula, Largiadèr Carlo R., Jennings Barbara A., Marinaki Anthony M., Sanderson Jeremy D., Kleibl Zdenek, Kleiblova Petra, Schwab Matthias, Zanger Ulrich M., Palles Claire, Tomlinson Ian, Gross Eva, van Kuilenburg André B. P., Punt Cornelis J. A., Koopman Miriam, Beijnen Jos H., Cats Annemieke, Schellens Jan H. M. Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data lancet oncology 2015;16 (16):1639-1650 [PubMed]
• van Huis-Tanja Lieke H., Ewing Ewoud, van der Straaten R. J. H. M., Swen Jesse J., Baak-Pablo Renée F., Punt C. J. A., Gelderblom A. J., Guchelaar Henk-Jan Clinical validation study of genetic markers for capecitabine efficacy in metastatic colorectal cancer patients Pharmacogenetics and genomics 2015;25 (6):279-288 [PubMed]
• Venderbosch Sabine, van Lent-van Vliet Shannon, de Haan Anton F. J., Ligtenberg Marjolijn J., Goossens Monique, Punt Cornelis J. A., Koopman Miriam, Nagtegaal Iris D. EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer PLoS ONE 2015;10 (4):e0124538 [PubMed]
• Pander Jan, van Huis-Tanja Lieke, Böhringer Stefan, van der Straaten Tahar, Gelderblom Hans, Punt Cornelis, Guchelaar Henk-Jan Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer PLoS ONE 2015;10 (7):e0131091 [PubMed]
• Punt Cornelis J. A., Nagtegaal Iris D., van de Velde Cornelis J., Beets-Tan Regina, Cats Annemieke, Hoogerbrugge Nicoline, Marijnen Corrie A. Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014 Ecancermedicalscience 2015;9:497 [PubMed]
• van den Broek Evert, Dijkstra Maurits J. J., Krijgsman Oscar, Sie Daoud, Haan Josien C., Traets Joleen J. H., van de Wiel Mark A., Nagtegaal Iris D., Punt Cornelis J. A., Carvalho Beatriz, Ylstra Bauke, Abeln Sanne, Meijer Gerrit A., Fijneman Remond J. A. High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer PLoS ONE 2015;10 (9):e0138141 [PubMed]
• Shi Qian, de Gramont Aimery, Grothey Axel, Zalcberg John, Chibaudel Benoist, Schmoll Hans-Joachim, Seymour Matthew T., Adams Richard, Saltz Leonard, Goldberg Richard M., Punt Cornelis J. A., Douillard Jean-Yves, Hoff Paulo M., Hecht Joel Randolph, Hurwitz Herbert, Díaz-Rubio Eduardo, Porschen Rainer, Tebbutt Niall C., Fuchs Charles, Souglakos John, Falcone Alfredo, Tournigand Christophe, Kabbinavar Fairooz F., Heinemann Volker, van Cutsem Eric, Bokemeyer Carsten, Buyse Marc, Sargent Daniel J. Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database Journal of clinical oncology 2015;33 (1):22-U47 [PubMed]
• Bol Kalijn F., Figdor Carl G., Aarntzen Erik Hjg, Welzen Marieke Eb, van Rossum Michelle M., Blokx Willeke Am, van de Rakt Mandy Wmm, Scharenborg Nicole M., de Boer Annemiek J., Pots Jeanette M., Olde Nordkamp Michel Am, van Oorschot Tom Gm, Mus Roel Dm, Croockewit Sandra Aj, Jacobs Joannes Fm, Schuler Gerold, Neyns Bart, Austyn Jonathan M., Punt Cornelis Ja, Schreibelt Gerty, de Vries I. Jolanda M. Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients Oncoimmunology 2015;4 (8):e1019197 [PubMed]
• Simkens Lieke H. J., van Tinteren Harm, Punt Cornelis J. A., Koopman Miriam Maintenance treatment in metastatic colorectal cancer lancet oncology 2015;16 (16):e582-e583 [PubMed]
• Simkens Lieke H. J., van Tinteren Harm, May Anne, ten Tije Albert J., Creemers Geert-Jan M., Loosveld Olaf J. L., de Jongh Felix E., Erdkamp Frans L. G., Erjavec Zoran, van der Torren Adelheid M. E., Tol Jolien, Braun Hans J. J., Nieboer Peter, van der Hoeven Jacobus J. M., Haasjes Janny G., Jansen Rob L. H., Wals Jaap, Cats Annemieke, Derleyn Veerle A., Honkoop Aafke H., Mol Linda, Punt Cornelis J. A., Koopman Miriam Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group Lancet 2015;385 (9980):1843-1852 [PubMed]
• Kordes Sil, Pollak Michael N., Zwinderman Aeilko H., Mathôt Ron A., Weterman Mariëtte J., Beeker Aart, Punt Cornelis J., Richel Dick J., Wilmink Johanna W. Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial lancet oncology 2015;16 (7):839-847 [PubMed]
• Simmer Femke, Venderbosch Sabine, Dijkstra Jeroen R., Vink-Börger Elisa M., Faber Claudius, Mekenkamp Leonie J., Koopman Miriam, de Haan Anton F., Punt Cornelis J., Nagtegaal Iris D. MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer Oncotarget 2015;6 (26):22996-23007 [PubMed]
• Venderbosch S., van Vliet S., Craenmehr M. H. C., Simmer F., de Haan A. F. J., Punt C. J. A., Koopman M., Nagtegaal I. D. Mitochondrial microsatellite instability in patients with metastatic colorectal cancer Virchows Archiv 2015;466 (5):495-502 [PubMed]
• Heijmen Linda, ter Voert Edwin E. G. W., Oyen Wim J. G., Punt Cornelis J. A., van Spronsen Dick Johan, Heerschap Arend, de Geus-Oei Lioe-Fee, van Laarhoven Hanneke W. M. Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer PLoS ONE 2015;10 (4):e0120823 [PubMed]
• Shapiro Joel, van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Hagen Pieter, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., ten Kate Fiebo J. W., Creemers Geert-Jan M., Punt Cornelis J. A., Plukker John Th M., Verheul Henk M. W., Bilgen Ernst J. Spillenaar, van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., Steyerberg Ewout W., van der Gaast Ate Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial lancet oncology 2015;16 (9):1090-1098 [PubMed]
• Ayez Ninos, van der Stok Eric P., de Wilt Hans, Radema Sandra A., van Hillegersberg Richard, Roumen Rudi M., Vreugdenhil Gerard, Tanis Pieter J., Punt Cornelis J., Dejong Cornelis H., Jansen Rob L., Verheul Henk M., de Jong Koert P., Hospers Geke A., Klaase Joost M., Legdeur Marie-Cecile, van Meerten Esther, Eskens Ferry A., van der Meer Nelly, van der Holt Bruno, Verhoef Cornelis, Grünhagen Dirk J. Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial BMC cancer 2015;15 (1):180 [PubMed]
• Venderbosch Sabine Outcome parameters in metastatic colorectal cancer 2015. 179p. ISBN 9789462992122. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Punt C. J., Nagtegaal I. D.; Co-supervisor: Koopman M.)
• van Gils C. W. M., de Groot S., Tan S. S., Redekop W. K., Koopman M., Punt C. J. A., Uyl-de Groot C. A. Real-world resource use and costs of adjuvant treatment for stage III colon cancer European journal of cancer care 2015;24 (3):321-332 [PubMed]
• Hugen Niek, Simmer Femke, Mekenkamp Leonie J. M., Koopman Miriam, van den Broek Evert, de Wilt Johannes H. W., Punt Cornelis J. A., Ylstra Bauke, Meijer Gerrit A., Nagtegaal Iris D. Reduced rate of copy number aberrations in mucinous colorectal carcinoma Oncotarget 2015;6 (28):25715-25725 [PubMed]
• Mol Linda, Koopman Miriam, Ottevanger Petronella B., Punt Cornelis J. A. RE: Generalizability of Trial Results to Elderly Medicare Patients With Advanced Solid Tumors Journal of the National Cancer Institute 2015;107 (6):djv104 [PubMed]
• Punt Cornelis J. A., Simkens Lieke H. J., Koopman Miriam Systemic treatment: maintenance compared with holiday American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting 2015;35:85-90 [PubMed]
• Bos A. C. R. K., van Erning F. N., van Gestel Y. R. B. M., Creemers G. J. M., Punt C. J. A., van Oijen M. G. H., Lemmens V. E. P. P. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer European journal of cancer (Oxford, England 2015;51 (17):2553-2561 [PubMed]
• Huiskens Joost, van Gulik Thomas M., van Lienden Krijn P., Engelbrecht Marc R. W., Meijer Gerrit A., van Grieken Nicole C. T., Schriek Jonne, Keijser Astrid, Mol Linda, Molenaar I. Quintus, Verhoef Cornelis, de Jong Koert P., Dejong Kees H. C., Kazemier Geert, Ruers Theo M., de Wilt Johanus H. W., van Tinteren Harm, Punt Cornelis J. A. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG) BMC cancer 2015;15 (1):365 [PubMed]
• Weickhardt A. J., Williams D. S., Lee C. K., Chionh F., Simes J., Murone C., Wilson K., Parry M. M., Asadi K., Scott A. M., Punt C. J. A., Nagtegaal I. D., Price T. J., Mariadason J. M., Tebbutt N. C. Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer British journal of cancer 2015;113 (1):37-45 [PubMed]

2014

• Haan J. C. Analysis of chromosomal copy number aberrations in gastrointestical cancerAmsterdam: Ipskamp Drukkers BV; 2014. 216p. ISBN 9789053830468. [UvA Dissertations Online] VUMC: Pathologie. (Supervisors: Meijer G. A., Punt C. J. A.; Co-supervisors: Ylstra B., Nagtegaal I. D.)
• Mulder S. F., Boers-Sonderen M. J., van der Heijden H. F. M., Vissers K. C. P., Punt C. J. A., van Herpen C. M. L. A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusion Targeted oncology 2014;9 (4):331-338 [PubMed]
• Lieu Christopher H., Renfro Lindsay A., de Gramont Aimery, Meyers Jeffrey P., Maughan Timothy S., Seymour Matthew T., Saltz Leonard, Goldberg Richard M., Sargent Daniel J., Eckhardt S. Gail, Eng Cathy, Adams R., Ajani J., Allegra C. J., Arnold D., Benson A. B., Bleiberg H., Bodoky G., Bonnetain F., Buyse M., Chibaudel B., Coqueret O., de Gramont A., Diaz-Rubio E., Douillard J. Y., Ellis L., Eng C., Falcone A., Chiara S., Fuchs C., Fujii M., Giantonio B. J., Goldberg R., Grothey A., Haller D., Hamilton S., Hammel P., Hausner P., Hecht J. R., Hochster H. S., Hoff P., Hurwitz H., Jonker D. J., Kaplan R., Kim G., Kopetz S., Labianca R., Larsen A., Lenz H. J., Punt C. J. A. Association of Age With Survival in Patients With Metastatic Colorectal Cancer: Analysis From the ARCAD Clinical Trials Program Journal of clinical oncology 2014;32 (27):2975-+ [PubMed]
• Mekenkamp Leonie J. M., Haan Josien C., Israeli Daniëlle, van Essen Hendrik F. B., Dijkstra Jeroen R., van Cleef Patricia, Punt Cornelis J. A., Meijer Gerrit A., Nagtegaal Iris D., Ylstra Bauke Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrent PLoS ONE 2014;9 (2):e86833 [PubMed]
• Price Timothy J., Segelov Eva, Burge Matthew, Haller Daniel G., Tebbutt Niall C., Karapetis Christos S., Punt Cornelis J. A., Pavlakis Nick, Arnold Dirk, Gibbs Peter, Shapiro Jeremy D. Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013 Expert review of anticancer therapy 2014;14 (12):1477-1493 [PubMed]
• Wimmers Florian, Aarntzen Erik H. J. G., Schreibelt Gerty, Jacobs Joannes F. M., Punt Cornelis J. A., Figdor Carl G., de Vries I. Jolanda M. Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy Oncoimmunology 2014;3 (1):e27219 [PubMed]
• van Huis-Tanja Lieke H., Kweekel Dina M., Lu Xiaobo, Franken Kees, Koopman Miriam, Gelderblom Hans, Antonini Ninja F., Punt Cornelis J. A., Guchelaar Henk-Jan, van der Straaten Tahar Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin Mutation research 2014;759:37-44 [PubMed]
• Sloothaak D. A. M., Gardenbroek T. J., Crezee J., Bemelman W. A., Punt C. J. A., Buskens C. J., Tanis P. J. Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis European journal of surgical oncology 2014;40 (11):1453-1458 [PubMed]
• Peeters M., Price T. J., Cervantes A., Sobrero A. F., Ducreux M., Hotko Y., André T., Chan E., Lordick F., Punt C. J. A., Strickland A. H., Wilson G., Ciuleanu T. E., Roman L., van Cutsem E., Tian Y., Sidhu R. Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer Annals of oncology 2014;25 (1):107-116 [PubMed]
• Haan Josien C., Labots Mariette, Rausch Christian, Koopman Miriam, Tol Jolien, Mekenkamp Leonie J. M., van de Wiel Mark A., Israeli Danielle, van Essen Hendrik F., van Grieken Nicole C. T., Voorham Quirinus J. M., Bosch Linda J. W., Qu Xueping, Kabbarah Omar, Verheul Henk M. W., Nagtegaal Iris D., Punt Cornelis J. A., Ylstra Bauke, Meijer Gerrit A. Genomic landscape of metastatic colorectal cancer Nature communications 2014;5:5457 [PubMed]
• Mulder Sasja F., Bertens Dirk, Desar Ingrid M. E., Vissers Kris C. P., Mulders Peter F. A., Punt Cornelis J. A., van Spronsen Dick-Johan, Langenhuijsen Johan F., Kessels Roy P. C., van Herpen Carla M. L. Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study BMC cancer 2014;14:219 [PubMed]
• Sloothaak D. A. M., Mirck B., Punt C. J. A., Bemelman W. A., van der Bilt J. D. W., D'Hoore A., Tanis P. J. Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review British journal of cancer 2014;111 (6):1112-1121 [PubMed]
• Tanis E., Nordlinger B., Mauer M., Sorbye H., van Coevorden F., Gruenberger T., Schlag P. M., Punt C. J. A., Ledermann J., Ruers T. J. M. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983 European journal of cancer (Oxford, England 2014;50 (5):912-919 [PubMed]
• Bol Kalijn F., Mensink Hanneke W., Aarntzen Erik H. J. G., Schreibelt Gerty, Keunen Jan E. E., Coulie Pierre G., de Klein Annelies, Punt Cornelis J. A., Paridaens Dion, Figdor Carl G., de Vries I. Jolanda M. Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients American journal of ophthalmology 2014;158 (5):939-947 [PubMed]
• Koen Talsma A., Shapiro Joel, Looman Caspar W. N., van Hagen Pieter, Steyerberg Ewout W., van der Gaast Ate, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., ten Kate Fiebo J. W., Creemers Geert-Jan, Punt Cornelis J. A., Plukker John T. M., Verheul Henk M. W., van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., van Rij Caroline Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival Annals of surgery 2014;260 (5):786-92; discussion 792-3 [PubMed]
• Venderbosch Sabine, Nagtegaal Iris D., Maughan Tim S., Smith Christopher G., Cheadle Jeremy P., Fisher David, Kaplan Richard, Quirke Philip, Seymour Matthew T., Richman Susan D., Meijer Gerrit A., Ylstra Bauke, Heideman Danielle A. M., de Haan Anton F. J., Punt Cornelis J. A., Koopman Miriam Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies Clinical cancer research 2014;20 (20):5322-5330 [PubMed]
• Heijmen L., ter Voert E. G. W., Punt C. J. A., Heerschap A., Oyen W. J. G., Bussink J., Sweep C. G. J., Laverman P., Span P. N., de Geus-Oei L. F., Boerman O. C., van Laarhoven H. W. M. Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model Contrast media & molecular imaging 2014;9 (3):237-245 [PubMed]
• Heijmen Linda Multimodality Imaging in colorectal cancerNijmegen: 2014. 186p. ISBN 9789461088260. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Medische Oncology. (Supervisor: Punt C. J. A.; Co-supervisors: van Laarhoven H. M. W., de Geus-Oei L. F.)
• Simkens Lieke H. J., Koopman Miriam, Punt Cornelis J. A. Optimal duration of systemic treatment in metastatic colorectal cancer Current opinion in oncology 2014;26 (4):448-453 [PubMed]
• Shapiro Joel, van Hagen Pieter, Lingsma Hester F., Wijnhoven Bas P. L., Biermann Katharina, ten Kate Fiebo J. W., Steyerberg Ewout W., van der Gaast Ate, van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Berge Henegouwen Mark I., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., Creemers Geert-Jan, Punt Cornelis J. A., Plukker John T. M., Verheul Henk M. W., Spillenaar Bilgen Ernst J., van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W. Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer Annals of surgery 2014;260 (5):807-814 [PubMed]
• Krens Lisanne L., Simkens Lieke H. J., Baas Jara M., Koomen Els R., Gelderblom Hans, Punt Cornelis J. A., Guchelaar Henk-Jan Statin use is not associated with improved progression free survival in cetuximab treated KRAS mutant metastatic colorectal cancer patients: results from the CAIRO2 study PLoS ONE 2014;9 (11):e112201 [PubMed]
• 't Lam-Boer Jorine, Mol Linda, Verhoef Cornelis, de Haan Anton F. J., Yilmaz Mette, Punt Cornelis J. A., de Wilt Johannes H. W., Koopman Miriam The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG) BMC cancer 2014;14:741 [PubMed]
• Dias M. M., Pignon J.-P., Karapetis C. S., Boige V., Glimelius B., Kweekel D. M., Lara P. N., Laurent-Puig P., Martinez-Balibrea E., Páez D., Punt C. J. A., Redman M. W., Toffoli G., Wadelius M., McKinnon R. A., Sorich M. J. The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis pharmacogenomics journal 2014;14 (5):424-431 [PubMed]

2013

• Busse Antonia, Rapion Jérôme, Fusi Alberto, Suciu Stefan, Nonnenmacher Anika, Santinami Mario, Kruit Wim H. J., Testori Alessandro, Punt Cornelis J. A., Dalgleish Angus G., Spatz Alan, Eggermont Alexander M. M., Keilholz Ulrich Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study) Cancer immunology, immunotherapy 2013;62 (7):1223-1233 [PubMed]
• Boers-Sonderen M. J., Desar I. M. E., Koopman M., Punt C. J., van Herpen C. M. L. Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancer Acta oncologica (Stockholm, Sweden) 2013;52 (8):1778-U1779 [PubMed]
• Mekenkamp Leonie J. M., Haan Josien C., Koopman Miriam, Vink-Börger M. Elisa, Israeli Daniëlle, Teerenstra Steven, Ylstra Bauke, Meijer Gerrit A., Punt Cornelis J. A., Nagtegaal Iris D. Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer Gut 2013;62 (1):94-101 [PubMed]
• Ligthart Sjoerd T., Coumans Frank A. W., Bidard Francois-Clement, Simkens Lieke H. J., Punt Cornelis J. A., de Groot Marco R., Attard Gerhardt, de Bono Johann S., Pierga Jean-Yves, Terstappen Leon W. M. M. Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer PLoS ONE 2013;8 (6):e67148 [PubMed]
• Punt C. J. A., Marijnen C. A. M., Nagtegaal I. D., van de Velde C. J. H. Colon carcinoom - Adjuvante systeemtherapiein: C. J. A. Punt, C. A. M. Marijnen, I. D. Nagtegaal, C. J. H. van de Velde, editors. Handboek colorectaal carcinoom. Utrecht: De Tijdstroom; 2013. p. 125-130, ISBN 9789058981967
• Mol Linda, Koopman Miriam, van Gils Chantal W. M., Ottevanger Petronella B., Punt Cornelis J. A. Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands Acta oncologica (Stockholm, Sweden) 2013;52 (5):950-955 [PubMed]
• van Huis-Tanja Lieke, Kweekel Dinemarie, Gelderblom Hans, Koopman Miriam, Punt Kees, Guchelaar Henk-Jan, van der Straaten Tahar Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples Pharmacogenomics 2013;14 (16):2005-2012 [PubMed]
• van Voorthuizen Theo, van Gulik Thomas M., Punt Cornelius J. A. Defining resectability of colorectal liver metastases: how and why? Colorectal Cancer 2013;2 (1):61-72
• Wennekes Lianne Development and validation of quality indicators for cancer careNijmegen: GVO drukkers & vormgevers B.V./Ponsen & Looijen, Ede; 2013. 179p. ISBN 9789076316710. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Oncologie. (Supervisors: Grol R. P. T. M., Punt C. J. A.; Co-supervisors: Hermens R. P. M. G., Ottevanger P. B.)
• Heijmen Linda, ter Voert Edwin E. G. W., Nagtegaal Iris D., Span Paul, Bussink Johan, Punt Cornelis J. A., de Wilt Johannes H. W., Sweep Fred C. G. J., Heerschap Arend, van Laarhoven Hanneke W. M. Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation European radiology 2013;23 (3):748-756 [PubMed]
• Groot D.J.A., Punt C. J. A. Er is geen indicatie voor adjuvante chemotherapie bij het rectumcarcinoom Nederlands tijdschrift voor oncologie 2013;10:243-245
• Punt C. J. A., Marijnen C. A. M., Nagtegaal I. D., van de Velde C. J. H. Handboek colorectaal carcinoomUtrecht: De Tijdstroom; 2013. ISBN 9789058981967
• Knijn Nikki, de Ridder Jannemarie A. M., Punt Cornelis J. A., de Wilt Johannes H. W., Nagtegaal Iris D. Histopathological evaluation of resected colorectal cancer liver metastases: what should be done? Histopathology 2013;63 (2):149-156 [PubMed]
• van de Loosdrecht A. A., Kallenberg C. G. M., Punt C. J. A. Immuuntherapie bij het colorectaalcarcinoomin: A. A. van de Loosdrecht, C. G. M. Kallenberg, editors. Handboek Immuuntherapie in de Interne Geneeskunde. Alphen aan den Rijn: Van Zuiden Communications BV; 2013. p. 389-394, ISBN 9789085232278
• Schreibelt Gerty, Bol Kalijn F., Aarntzen Erik H. J. G., Gerritsen Winald R., Punt Cornelis J. A., Figdor Carl G., de Vries I. Jolanda M. Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy Oncoimmunology 2013;2 (6):e24440 [PubMed]
• Aarntzen Erik H. J. G., Srinivas Mangala, Radu Caius G., Punt Cornelis J. A., Boerman Otto C., Figdor Carl G., Oyen Wim J. G., de Vries I. Jolanda M. In vivo imaging of therapy-induced anti-cancer immune responses in humans Cellular and molecular life sciences 2013;70 (13):2237-2257 [PubMed]
• Valtorta Emanuele, Misale Sandra, Sartore-Bianchi Andrea, Nagtegaal Iris D., Paraf François, Lauricella Calogero, Dimartino Valentina, Hobor Sebastijan, Jacobs Bart, Ercolani Cristiana, Lamba Simona, Scala Elisa, Veronese Silvio, Laurent-Puig Pierre, Siena Salvatore, Tejpar Sabine, Mottolese Marcella, Punt Cornelis J. A., Gambacorta Marcello, Bardelli Alberto, Di Nicolantonio Federica KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy International journal of cancer. Journal international du cancer 2013;133 (5):1259-1265 [PubMed]
• Punt C. J. A., Marijnen C. A. M., Nagtegaal I. D., van de Velde C. J. H. Metastasen op afstand - Adjuvante systeemtherapie na radicale metastasectomiein: C. J. A. Punt, C. A. M. Marijnen, I. D. Nagtegaal, C. J. H. van de Velde, editors. Handboek colorectaal carcinoom. Utrecht: De Tijdstroom; 2013. p. 215-218, ISBN 9789058981967
• Punt C. J. A., Marijnen C. A. M., Nagtegaal I. D., van de Velde C. J. H. Metastasen op afstand - Systemische therapiein: C. J. A. Punt, C. A. M. Marijnen, I. D. Nagtegaal, C. J. H. van de Velde, editors. Handboek colorectaal carcinoom. Utrecht: De Tijdstroom; 2013. p. 207-217, ISBN 9789058981967
• Punt C. J. A., Marijnen C. A. M., Nagtegaal I. D., van de Velde C. J. H. Metastasen op afstand - Targeted therapiein: C. J. A. Punt, C. A. M. Marijnen, I. D. Nagtegaal, C. J. H. van de Velde, editors. Handboek colorectaal carcinoom. Utrecht: De Tijdstroom; 2013. p. 207-217, ISBN 9789058981967
• Aarntzen E. H. J. G. Monitoring immune responses in dendritic cell based vaccination; with a focus on in vivo imagingNijmegen: Ipskamp Drukkers BV, Enschede; 2013. 249p. ISBN 9789461915764. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Oncologie. (Supervisors: Punt C. J. A., Figdor C. G., de Vries I. J. M.; Co-supervisor: Jacobs J. F. M.)
• Heijmen L., Punt C. J. A., ter Voert E. G. W., de Geus-Oei L. F., Heerschap A., Bussink J., Sweep C. G. J., Zerbi V., Oyen W. J. G., Span P. N., Boerman O., van Laarhoven H. W. M. Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach Investigational new drugs 2013;31 (4):881-890 [PubMed]
• van Huis-Tanja Lieke H., Gelderblom Hans, Punt Cornelis J. A., Guchelaar Henk-Jan MTHFR polymorphisms and capecitabine-induced toxicity in patients with metastatic colorectal cancer Pharmacogenetics and genomics 2013;23 (4):208-218 [PubMed]
• tel Jurjen, Aarntzen Erik H. J. G., Baba Tetsuro, Schreibelt Gerty, Schulte Barbara M., Benitez-Ribas Daniel, Boerman Otto C., Croockewit Sandra, Oyen Wim J. G., van Rossum Michelle, Winkels Gregor, Coulie Pierre G., Punt Cornelis J. A., Figdor Carl G., de Vries I. Jolanda M. Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients Cancer research 2013;73 (3):1063-1075 [PubMed]
• Sloothaak D. A. M., Geijsen D. E., van Leersum N. J., Punt C. J. A., Buskens C. J., Bemelman W. A., Tanis P. J. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer British journal of surgery 2013;100 (7):933-939 [PubMed]
• Ribas Antoni, Kefford Richard, Marshall Margaret A., Punt Cornelis J. A., Haanen John B., Marmol Maribel, Garbe Claus, Gogas Helen, Schachter Jacob, Linette Gerald, Lorigan Paul, Kendra Kari L., Maio Michele, Trefzer Uwe, Smylie Michael, McArthur Grant A., Dreno Brigitte, Nathan Paul D., Mackiewicz Jacek, Kirkwood John M., Gomez-Navarro Jesus, Huang Bo, Pavlov Dmitri, Hauschild Axel Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma Journal of clinical oncology 2013;31 (5):616-622 [PubMed]
• Franken Margreet G., van Gils Chantal W. M., Gaultney Jennifer G., Delwel Gepke O., Goettsch Wim, Huijgens Peter C., Steenhoek Adri, Punt Cornelis J. A., Koopman Miriam, Redekop William K., Uyl-de Groot Carin A. Practical feasibility of outcomes research in oncology: Lessons learned in assessing drug use and cost-effectiveness in The Netherlands European journal of cancer (Oxford, England 2013;49 (1):8-16 [PubMed]
• van Kessel C. S., Samim M., Koopman M., van den Bosch M. A. A. J., Borel Rinkes I. H. M., Punt C. J. A., van Hillegersberg R. Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases European journal of cancer (Oxford, England 2013;49 (11):2486-2493 [PubMed]
• van Gils Chantal W. M., de Groot Saskia, Redekop William K., Koopman Miriam, Punt Cornelis J. A., Uyl-de Groot Carin A. Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence PharmacoEconomics 2013;31 (8):703-718 [PubMed]
• van Gils Chantal W. M. Real-world cost-effectiveness: potential & pitfalls in the context of conditional reimbursementRotterdam: Optima Grafische Communicatie, Rotterdam; 2013. 214p. ISBN 9789461694539. [UvA Dissertations Online] Erasmus Universiteit Rotterdam: Oncologie. (Supervisors: Uyl-de Groot C. A., Punt C. J. A.; Co-supervisor: Redekop W. K.)
• Punt C. J. A., Marijnen C. A. M., Nagtegaal I. D., van de Velde C. J. H. Rectumcarcinoom - Adjuvante systeemtherapiein: C. J. A. Punt, C. A. M. Marijnen, I. D. Nagtegaal, C. J. H. van de Velde, editors. Handboek colorectaal carcinoom. Utrecht: De Tijdstroom; 2013. p. 173-174, ISBN 9789058981967
• Aarntzen Erik H. J. G., Srinivas Mangala, Schreibelt Gerty, Heerschap Arend, Punt Cornelius J. A., Figdor Carl G., Oyen Wim J., de Vries I. Jolanda M. Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination Oncoimmunology 2013;2 (7):e24661 [PubMed]
• Aggarwal C., Meropol N. J., Punt C. J., Iannotti N., Saidman B. H., Sabbath K. D., Gabrail N. Y., Picus J., Morse M. A., Mitchell E., Miller M. C., Cohen S. J. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer Annals of oncology 2013;24 (2):420-428 [PubMed]
• ter Voert E. G. W., Heijmen L., de Wilt J. H. W., Bussink J., Punt C. J. A., van Laarhoven H. W. M., Heerschap A. Reproducibility and Biological Basis of In Vivo T-2* Magnetic Resonance Imaging of Liver Metastasis of Colorectal Cancer Magnetic resonance in medicine 2013;70 (4):1145-1152 [PubMed]
• Punt C. J. A., Marijnen C. A. M., Nagtegaal I. D., van de Velde C. J. H. Speciële onderwerpen - Klinisch Wetenschappelijk Onderzoekin: C. J. A. Punt, C. A. M. Marijnen, I. D. Nagtegaal, C. J. H. van de Velde, editors. Handboek colorectaal carcinoom. Utrecht: De Tijdstroom; 2013. p. 207-2014, ISBN 9789058981967
• Mekenkamp Leonie J. M. Studies in colorectal cancer metastases: implications for clinical practiceNijmegen: Gildeprint; 2013. 202p. ISBN 9789090274270. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Oncologie. (Supervisors: Punt C. J. A., Nagtegaal I. D.; Co-supervisor: Koopman M.)
• Aarntzen Erik H. J. G., de Vries I. Jolanda M., Lesterhuis W. Joost, Schuurhuis Danita, Jacobs Joannes F. M., Bol Kalijn, Schreibelt Gerty, Mus Roel, de Wilt Johannes H. W., Haanen John B. A. G., Schadendorf Dirk, Croockewit Alexandra, Blokx Willeke A. M., van Rossum Michelle M., Kwok William W., Adema Gosse J., Punt Cornelis J. A., Figdor Carl G. Targeting CD4(+) T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination Cancer research 2013;73 (1):19-29 [PubMed]
• Aarntzen Erik H. J. G., Srinivas Mangala, Bonetto Fernando, Cruz Luis J., Verdijk Pauline, Schreibelt Gerty, van de Rakt Mandy, Lesterhuis W. Joost, van Riel Maichel, Punt Cornelius J. A., Adema Gosse J., Heerschap Arend, Figdor Carl G., Oyen Wim J., de Vries I. Jolanda M. Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells Clinical cancer research 2013;19 (6):1525-1533 [PubMed]

2012

• van Gils Chantal W. M., Koopman Miriam, Mol Linda, Redekop William K., Uyl-de Groot Carin A., Punt Cornelis J. A. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands Acta oncologica (Stockholm, Sweden) 2012;51 (1):57-64 [PubMed]
• Punt C. J. A. Bevacizumab voor gemetastaseerd colorectaalcarcinoom in de dagelijkse praktijk Nederlands tijdschrift voor oncologie 2012;9:54-56
• Mekenkamp Leonie J. M., Tol Jolien, Dijkstra Jeroen R., de Krijger Inge, Vink-Börger M. Elisa, van Vliet Shannon, Teerenstra Steven, Kamping Eveline, Verwiel Eugène, Koopman Miriam, Meijer Gerrit A., van Krieken J. Han J. M., Kuiper Roland, Punt Cornelis J. A., Nagtegaal Iris D. Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients BMC cancer 2012;12:292 [PubMed]
• Uphoff Eleonora P. M. M., Wennekes Lianne, Punt Cornelis J. A., Grol Richard P. T. M., Wollersheim Hub C. H., Hermens Rosella P. M. G., Ottevanger Petronella B. Development of generic quality indicators for patient-centered cancer care by using a RAND modified Delphi method Cancer nursing 2012;35 (1):29-37 [PubMed]
• Heijmen Linda, van Laarhoven Hanneke W. M., Punt Cornelis J. A., van den Hurk Desiree, van der Drift Miep A., Ottevanger Petronella B., Timmer-Bonte Johanna N. H. Encouraging results in older patients receiving chemotherapy: a retrospective analysis of treatment guideline adherence in daily practice Geriatrics & gerontology international 2012;12 (1):80-85 [PubMed]
• Aarntzen Erik H. J. G., de Vries I. Jolanda M., Göertz Joop H., Beldhuis-Valkis Marjo, Brouwers Huberdina M. L. M., van de Rakt Mandy W. M. M., van der Molen Renate G., Punt Cornelis J. A., Adema Gosse J., Tacken Paul J., Joosten Irma, Jacobs Joannes F. M. Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters Cancer immunology, immunotherapy 2012;61 (11):2003-2011 [PubMed]
• Aarntzen Erik H. J. G., Srinivas Mangala, Punt Cornelius J. A., Figdor Carl G., Oyen Wim J. G., de Vries I. Jolanda M. Insight into the dynamics, localization and magnitude of antigen-specific immune responses by [(18)F]FLT PET imaging Oncoimmunology 2012;1 (5):744-745 [PubMed]
• Eggermont Alexander M. M., Suciu Stefan, Testori Alessandro, Santinami Mario, Kruit Wim H. J., Marsden Jeremy, Punt Cornelis J. A., Salès François, Dummer Reinhard, Robert Caroline, Schadendorf Dirk, Patel Poulam M., de Schaetzen Gaetan, Spatz Alan, Keilholz Ulrich Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma Journal of clinical oncology 2012;30 (31):3810-3818 [PubMed]
• Mekenkamp Leonie J. M., Heesterbeek Karin J., Koopman Miriam, Tol Jolien, Teerenstra Steven, Venderbosch Sabine, Punt Cornelis J. A., Nagtegaal Iris D. Mucinous adenocarcinomas: Poor prognosis in metastatic colorectal cancer European journal of cancer (Oxford, England 2012;48 (4):501-509 [PubMed]
• Venderbosch Sabine, Doornebal Joan, Teerenstra Steven, Lemmens Wim, Punt Cornelis J. A., Koopman Miriam Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: A retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG) Acta oncologica (Stockholm, Sweden) 2012;51 (7):831-839 [PubMed]
• Klaver Y. L. B., Simkens L. H. J., Lemmens V. E. P. P., Koopman M., Teerenstra S., Bleichrodt R. P., de Hingh I. H. J. T., Punt C. J. A. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy European journal of surgical oncology 2012;38 (7):617-623 [PubMed]
• Dulos John, Carven Gregory J., van Boxtel Susan J., Evers Sabine, Driessen-Engels Lilian J. A., Hobo Willemijn, Gorecka Monika A., de Haan Anton F. J., Mulders Peter, Punt Cornelis J. A., Jacobs Joannes F. M., Schalken Jack A., Oosterwijk Egbert, van Eenennaam Hans, Boots Annemieke M. PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer Journal of immunotherapy (Hagerstown, Md. 2012;35 (2):169-178 [PubMed]
• van Hagen P., Hulshof M. C. C. M., van Lanschot J. J. B., Steyerberg E. W., van Berge Henegouwen M. I., Wijnhoven B. P. L., Richel D. J., Nieuwenhuijzen G. A. P., Hospers G. A. P., Bonenkamp J. J., Cuesta M. A., Blaisse R. J. B., Busch O. R. C., ten Kate F. J. W., Creemers G.-J., Punt C. J. A., Plukker J. T. M., Verheul H. M. W., Spillenaar Bilgen E. J., van Dekken H., van der Sangen M. J. C., Rozema T., Biermann K., Beukema J. C., Piet A. H. M., van Rij C. M., Reinders J. G., Tilanus H. W., van der Gaast A., Bergman J. J. G. H. M., Bartelsman J. F., Bissumbar A., Blom R. L., Geijsen E. D., van Heijl M., Obertop H., Koning C. C. E., Offerhaus G. J., Omloo J. M., Wilmink H., Aparicio Pages M. N., van den Nieuwenhof-Biesheuvel L., Eijkenboom W. M. H., Koppert L. B., Meijer D. A., Siersema P. D., Spaander M. C. V., Verheij C., Vollebregt C., van Krieken J. H. J. M. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer New England journal of medicine 2012;366 (22):2074-2084 [PubMed]
• Ruers T., Punt C., van Coevorden F., Pierie J. P. E. N., Borel-Rinkes I., Ledermann J. A., Poston G., Bechstein W., Lentz M. A., Mauer M., van Cutsem E., Lutz M. P., Nordlinger B. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004) Annals of oncology 2012;23 (10):2619-2626 [PubMed]
• Mekenkamp L. J. M., Heesterbeek C. J., Punt C. J. A., Nagtegaal I. D. Reply letter to: Signet ring cell carcinoma as a potential confounding factor in the analysis of outcomes with colorectal mucinous adenocarcinoma European journal of cancer (Oxford, England 2012;48 (16):3128-3129
• Heijmen Linda, de Geus-Oei Lioe-Fee, de Wilt Johannes H. W., Visvikis Dimitris, Hatt Mathieu, Visser Eric P., Bussink Johan, Punt Cornelis J. A., Oyen Wim J. G., van Laarhoven Hanneke W. M. Reproducibility of functional volume and activity concentration in F-18-FDG PET/CT of liver metastases in colorectal cancer European journal of nuclear medicine and molecular imaging 2012;39 (12):1858-1867 [PubMed]
• Aarntzen Erik H. J. G., Bol Kalijn, Schreibelt Gerty, Jacobs Joannes F. M., Lesterhuis W. Joost, van Rossum Michelle M., Adema Gosse J., Figdor Carl G., Punt Cornelis J. A., de Vries I. Jolanda M. Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma Cancer research 2012;72 (23):6102-6110 [PubMed]
• Heijmen Linda, Verstappen Maartje C. H. M., ter Voert Edwin E. G. W., Punt Cornelis J. A., Oyen Wim J. G., de Geus-Oei Lioe-Fee, Hermans John J., Heerschap Arend, van Laarhoven Hanneke W. M. Tumour response prediction by diffusion-weighted MR imaging: Ready for clinical use? Critical reviews in oncology/hematology 2012;83 (2):194-207 [PubMed]
• Eggermont Alexander M. M., Suciu Stefan, Testori Alessandro, Kruit Wim H., Marsden Jeremy, Punt Cornelis J., Santinami Mario, Salès François, Schadendorf Dirk, Patel Poulam, Dummer Reinhard, Robert Caroline, Keilholz Ulrich, Yver Antoine, Spatz Alan Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991 European journal of cancer (Oxford, England 2012;48 (2):218-225 [PubMed]
• Aarntzen Erik H. J. G., Schreibelt Gerty, Bol Kalijn, Lesterhuis W. Joost, Croockewit Alexandra J., de Wilt Johannes H. W., van Rossum Michelle M., Blokx Willeke A. M., Jacobs Joannes F. M., Duiveman-de Boer Tjitske, Schuurhuis Danita H., Mus Roel, Thielemans Kris, de Vries I. Jolanda M., Figdor Carl G., Punt Cornelis J. A., Adema Gosse J. Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4(+) and CD8(+) T Cells Responses in Stage III and IV Melanoma Patients Clinical cancer research 2012;18 (19):5460-5470 [PubMed]

2011

• Punt Cornelis J. A., Mol Linda, Koopman Miriam Bevacizumab and cancer treatment-related mortality JAMA 2011;305 (22):2292; author reply 2292-2292; author reply 2293 [PubMed]
• Lesterhuis W. Joost, Haanen John B. A. G., Punt Cornelis J. A. Cancer immunotherapy--revisited Nature reviews. Drug discovery 2011;10 (8):591-600 [PubMed]
• Mulder Sasja F., Jacobs Joannes F. M., Olde Nordkamp Michel A. M., Galama Joep M. D., Desar Ingrid M. E., Torensma Ruurd, Teerenstra Steven, Mulders Peter F. A., Vissers Kris C. P., Punt Cornelis J. A., de Vries I. Jolanda M., van Herpen Carla M. L. Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination Clinical cancer research 2011;17 (13):4541-4549 [PubMed]
• de Bruijn Menno T., Raats Daniëlle A. E., Tol Jolien, Hinrichs John, Teerenstra Steven, Punt Cornelis J. A., Borel Rinkes Inne H. M., Kranenburg Onno Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer Anticancer research 2011;31 (4):1379-1385 [PubMed]
• Wennekes Lianne, Ottevanger Petronella B., Raemaekers John M., Schouten Harry C., de Kok Marjorie W. E., Punt Cornelis J. A., Grol Richard P., Wollersheim Hub C., Hermens Rosella P. Development and measurement of guideline-based indicators for patients with non-Hodgkin's lymphoma Journal of clinical oncology 2011;29 (11):1436-1444 [PubMed]
• Aarntzen Erik H. J. G., Srinivas Mangala, de Wilt Johannes H. W., Jacobs Joannes F. M., Lesterhuis W. Joost, Windhorst Albert D., Troost Esther G., Bonenkamp Johannes J., van Rossum Michelle M., Blokx Willeke A. M., Mus Roel D., Boerman Otto C., Punt Cornelis J. A., Figdor Carl G., Oyen Wim J. G., de Vries I. Jolanda M. Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging Proceedings of the National Academy of Sciences of the United States of America 2011;108 (45):18396-18399 [PubMed]
• Patel Poulam M., Suciu Stefan, Mortier Laurent, Kruit Wim H., Robert Caroline, Schadendorf Dirk, Trefzer Uwe, Punt Cornelis J. A., Dummer Reinhard, Davidson Neville, Becker Juergen, Conry Robert, Thompson John A., Hwu Wen-Jen, Engelen Kristel, Agarwala Sanjiv S., Keilholz Ulrich, Eggermont Alexander M. M., Spatz Alain Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032) European journal of cancer (Oxford, England 2011;47 (10):1476-1483 [PubMed]
• de Vries I. Jolanda M., Castelli Chiara, Huygens Caroline, Jacobs Joannes F. M., Stockis Julie, Schuler-Thurner Beatrice, Adema Gosse J., Punt Cornelis J. A., Rivoltini Licia, Schuler Gerold, Coulie Pierre G., Lucas Sophie Frequency of circulating Tregs with demethylated FOXP3 intron 1 in melanoma patients receiving tumor vaccines and potentially Treg-depleting agents Clinical cancer research 2011;17 (4):841-848 [PubMed]
• Pander J. Genetic predictors for metastatic colorectal cancer treatment efficacy 2011. [UvA Dissertations Online] Universiteit Leiden: Geneeskunde. (Supervisors: Guchelaar H. J., Gelderblom H., Punt C. J. A.)
• Simkens Lieke H. J., Koopman Miriam, Mol Linda, Veldhuis Gerrit Jan, ten Bokkel Huinink Daan, Muller Erik W., Derleyn Veerle A., Teerenstra Steven, Punt Cornelis J. A. Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy European journal of cancer (Oxford, England 2011;47 (17):2560-2567 [PubMed]
• Knijn N., Mekenkamp L. J. M., Klomp M., Vink-Börger M. E., Tol J., Teerenstra S., Meijer J. W. R., Tebar M., Riemersma S., van Krieken J. H. J. M., Punt C. J. A., Nagtegaal I. D. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients British journal of cancer 2011;104 (6):1020-1026 [PubMed]
• de Krijger Inge, Mekenkamp Leonie J. M., Punt Cornelis J. A., Nagtegaal Iris D. MicroRNAs in colorectal cancer metastasis Journal of pathology 2011;224 (4):438-447 [PubMed]
• Pander J., Wessels J. A. M., Gelderblom H., van der Straaten T., Punt C. J. A., Guchelaar H.-J. Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer Annals of oncology 2011;22 (5):1147-1153 [PubMed]
• Lesterhuis W. Joost, Punt Cornelis J. A., Hato Stanleyson V., Eleveld-Trancikova Dagmar, Jansen Bastiaan J. H., Nierkens Stefan, Schreibelt Gerty, de Boer Annemiek, van Herpen Carla M. L., Kaanders Johannes H., van Krieken Johan H. J. M., Adema Gosse J., Figdor Carl G., de Vries I. Jolanda M. Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice Journal of clinical investigation 2011;121 (8):3100-3108 [PubMed]
• Venderbosch Sabine, de Wilt Johannes H., Teerenstra Steven, Loosveld Olaf J., van Bochove Aart, Sinnige Harm A., Creemers Geert-Jan M., Tesselaar Margot E., Mol Linda, Punt Cornelis J. A., Koopman Miriam Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature Annals of surgical oncology 2011;18 (12):3252-3260 [PubMed]
• Deenen Maarten J., Tol Jolien, Burylo Artur M., Doodeman Valerie D., de Boer Anthonius, Vincent Andrew, Guchelaar Henk-Jan, Smits Paul H. M., Beijnen Jos H., Punt Cornelis J. A., Schellens Jan H. M., Cats Annemieke Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer Clinical cancer research 2011;17 (10):3455-3468 [PubMed]
• Lesterhuis W. Joost, de Vries I. Jolanda M., Schreibelt Gerty, Lambeck Annechien J. A., Aarntzen Erik H. J. G., Jacobs Joannes F. M., Scharenborg Nicole M., van de Rakt Mandy W. M. M., de Boer Annemiek J., Croockewit Sandra, van Rossum Michelle M., Mus Roel, Oyen Wim J. G., Boerman Otto C., Lucas Sophie, Adema Gosse J., Punt Cornelis J. A., Figdor Carl G. Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients Clinical cancer research 2011;17 (17):5725-5735 [PubMed]
• Bokkerink Guus M. J., de Graaf Eelco J. R., Punt Cornelis J. A., Nagtegaal Iris D., Rütten Heidi, Nuyttens Joost J. M. E., van Meerten Esther, Doornebosch Pascal G., Tanis Pieter J., Derksen Eric J., Dwarkasing Roy S., Marijnen Corrie A. M., Cats Annemieke, Tollenaar Rob A. E. M., de Hingh Ignace H. J. T., Rutten Harm J. T., van der Schelling George P., ten Tije Albert J., Leijtens Jeroen W. A., Lammering Guido, Beets Geerard L., Aufenacker Theo J., Pronk Apollo, Manusama Eric R., Hoff Christiaan, Bremers Andreas J. A., Verhoef Cornelelis, de Wilt Johannes H. W. The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery BMC surgery 2011;11 (1):34 [PubMed]
• Knijn N., Tol J., Koopman M., Werter M. J. B. P., Imholz A. L. T., Valster F. A. A., Mol L., Vincent A. D., Teerenstra S., Punt C. J. A. The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients European journal of cancer (Oxford, England 2011;47 (3):369-374 [PubMed]
• Lesterhuis W. Joost, Schreibelt Gerty, Scharenborg Nicole M., Brouwer H. Mary-lène H., Gerritsen Marie-Jeanne P., Croockewit Sandra, Coulie Pierre G., Torensma Ruurd, Adema Gosse J., Figdor Carl G., de Vries I. Jolanda M., Punt Cornelis J. A. Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used Cancer immunology, immunotherapy 2011;60 (2):249-260 [PubMed]

2010

• Levenga T. H. 4. Allogeneic stem cell transplantation: exploration of new indications and strategies to exploit graft-versus-tumor immunity for cancer treatment 2010. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Geneeskunde. (Supervisors: de Witte T., Punt C. J. A.)
• Lesterhuis W. J., de Vries I. J. M., Aarntzen E. A., de Boer Annemiek, Scharenborg N. M., van de Rakt M., van Spronsen D.-J., Preijers F. W., Figdor C. G., Adema G. J., Punt C. J. A. A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients British journal of cancer 2010;103 (9):1415-1421 [PubMed]
• Mol L., Koopman M., Ottevanger P. B., Punt C. J. A. A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer Annals of oncology 2010;21 (2):415-418 [PubMed]
• Gambarota Giulio, van Laarhoven H. W. M., Philippens M., Peeters W. J. M., Rijken P., van der Kogel A., Punt C. J. A., Heerschap A. Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma Applied magnetic resonance 2010;38 (3):349-360 [PubMed]
• Tol J., Koopman M., Miller M. C., Tibbe A., Cats A., Creemers G. J. M., Vos A. H., Nagtegaal I. D., Terstappen L. W. M. M., Punt C. J. A. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents Annals of oncology 2010;21 (5):1006-1012 [PubMed]
• Mekenkamp L. J. M., Koopman M., Teerenstra S., van Krieken J. H. J. M., Mol L., Nagtegaal I. D., Punt C. J. A. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases British journal of cancer 2010;103 (2):159-164 [PubMed]
• Schreibelt Gerty, Benitez-Ribas Daniel, Schuurhuis Danita, Lambeck Annechien J. A., van Hout-Kuijer Maaike, Schaft Niels, Punt Cornelis J. A., Figdor Carl G., Adema Gosse J., de Vries I. Jolanda M. Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells Blood 2010;116 (4):564-574 [PubMed]
• Pander Jan, Gelderblom Hans, Antonini Ninja F., Tol Jolien, van Krieken Johan H. J. M., van der Straaten Tahar, Punt Cornelis J. A., Guchelaar Henk-Jan Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer European journal of cancer (Oxford, England 2010;46 (10):1829-1834 [PubMed]
• Knijn Nikki, Tol Jolien, Punt Cornelis J. A. Current issues in the targeted therapy of advanced colorectal cancer Discovery medicine 2010;9 (47):328-336 [PubMed]
• Lesterhuis W. J. Dendritic cells in cancer immunotherapy 2010. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Geneeskunde. (Supervisors: Punt C. J. A., Adema G. J.)
• Jacobs Joannes F. M., Punt Cornelis J. A., Lesterhuis W. Joost, Sutmuller Roger P. M., Brouwer H. Mary-lène H., Scharenborg Nicole M., Klasen Ina S., Hilbrands Luuk B., Figdor Carl G., de Vries I. Jolanda M., Adema Gosse J. Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients Clinical cancer research 2010;16 (20):5067-5078 [PubMed]
• Punt Cornelis J. A. Drug development in advanced esophagogastric cancer: the art of extrapolation Journal of clinical oncology 2010;28 (25):3907-3909 [PubMed]
• Quirke Phil, Cuvelier Claude, Ensari Arzu, Glimelius Bengt, Laurberg Søren, Ortiz Hector, Piard Francoise, Punt Cornelis J. A., Glenthoj Anders, Pennickx Freddy, Seymour Matt, Valentini Vincenzo, Williams Geraint, Nagtegaal Iris D. Evidence-based medicine: the time has come to set standards for staging Journal of pathology 2010;221 (4):357-360 [PubMed]
• Tol Jolien, Dijkstra Jeroen R., Vink-Börger Marianne E., Nagtegaal Iris D., Punt Cornelis J. A., van Krieken Johan H. J. M., Ligtenberg Marjolijn J. L. High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue Journal of cellular and molecular medicine 2010;14 (8):2122-2131 [PubMed]
• Lesterhuis W. Joost, de Vries I. Jolanda M., Schreibelt G., Schuurhuis Danita H., Aarntzen Erik H., de Boer Annemiek, Scharenborg Nicole M., van de Rakt Mandy, Hesselink Erik J., Figdor Carl G., Adema Gosse J., Punt Cornelis J. A. Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients Anticancer research 2010;30 (12):5091-5097 [PubMed]
• van Iersel L. B. J., Koopman M., van de Velde C. J. H., Mol L., van Persijn van Meerten E. L., Hartgrink H. H., Kuppen P. J. K., Vahrmeijer A. L., Nortier J. W. R., Tollenaar R. A. E. M., Punt C., Gelderblom H. Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy Annals of oncology 2010;21 (8):1662-1667 [PubMed]
• Tol Jolien, Dijkstra Jeroen R., Klomp Marjolein, Teerenstra Steven, Dommerholt Martin, Vink-Börger M. Elisa, van Cleef Patricia H., van Krieken J. Han, Punt Cornelis J. A., Nagtegaal Iris D. Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab European journal of cancer (Oxford, England 2010;46 (11):1997-2009 [PubMed]
• Tol Jolien, Punt Cornelis J. A. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review Clinical therapeutics 2010;32 (3):437-453 [PubMed]
• van Laarhoven Hanneke W. M., Fiedler Walter, Desar Ingrid M. E., van Asten Jack J. A., Marréaud Sandrine, Lacombe Denis, Govaerts Anne-Sophie, Bogaerts Jan, Lasch Peter, Timmer-Bonte Johanna N. H., Lambiase Antonio, Bordignon Claudio, Punt Cornelis J. A., Heerschap Arend, van Herpen Carla M. L. Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041) Clinical cancer research 2010;16 (4):1315-1323 [PubMed]
• van Cruijsen Hester, Voest Emile E., Punt Cornelis J. A., Hoekman Klaas, Witteveen Petronella O., Meijerink Martijn R., Puchalski Thomas A., Robertson Jane, Saunders Owain, Jürgensmeier Juliane M., van Herpen Carla M. L., Giaccone Giuseppe Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours European journal of cancer (Oxford, England 2010;46 (5):901-911 [PubMed]
• Bouwhuis Marna G., Suciu Stefan, Testori Alessandro, Kruit Wim H., Salès François, Patel Poulam, Punt Cornelis J., Santinami Mario, Spatz Alain, ten Hagen Timo L. M., Eggermont Alexander M. M. Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991 Journal of clinical oncology 2010;28 (14):2460-2466 [PubMed]
• Peeters Marc, Price Timothy Jay, Cervantes Andrés, Sobrero Alberto F., Ducreux Michel, Hotko Yevhen, André Thierry, Chan Emily, Lordick Florian, Punt Cornelis J. A., Strickland Andrew H., Wilson Gregory, Ciuleanu Tudor-Eliade, Roman Laslo, van Cutsem Eric, Tzekova Valentina, Collins Simon, Oliner Kelly S., Rong Alan, Gansert Jennifer Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer Journal of clinical oncology 2010;28 (31):4706-4713 [PubMed]
• Pander J., Gelderblom H., van der Straaten T., Punt C. J. A., Guchelaar H.-J. Regarding: 'Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array' British journal of cancer 2010;102 (12):1791-1792 [PubMed]
• Tol J. Targeted therapy in metastatic colorectal cancer 2010. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Geneeskunde. (Supervisors: Punt C. J. A., van Krieken J. H. J. M.)
• Simkens L. H. J., Tol J., Terstappen L. W. M. M., Teerenstra S., Punt C. J. A., Nagtegaal I. D. The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab Annals of oncology 2010;21 (12):2447-2448 [PubMed]

2009

• Bottomley Andrew, Coens Corneel, Suciu Stefan, Santinami Mario, Kruit Willem, Testori Alessandro, Marsden Jeremy, Punt Cornelis, Salès François, Gore Martin, Mackie Rona, Kusic Zvonko, Dummer Reinhard, Patel Poulam, Schadendorf Dirk, Spatz Alain, Keilholz Ulrich, Eggermont Alexander Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group Journal of clinical oncology 2009;27 (18):2916-2923 [PubMed]
• Koopman Miriam, Venderbosch Sabine, Nagtegaal Iris D., van Krieken Johan H., Punt Cornelis J. A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned? European journal of cancer (Oxford, England 2009;45 (11):1935-1949 [PubMed]
• Bouwhuis Marna G., Suciu Stefan, Collette Sandra, Aamdal Steinar, Kruit Wim H., Bastholt Lars, Stierner Ulrika, Salès François, Patel Poulam, Punt Cornelis J. A., Hernberg Micaela, Spatz Alain, ten Hagen Timo L. M., Hansson Johan, Eggermont Alexander M. M. Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon Journal of the National Cancer Institute 2009;101 (12):869-877 [PubMed]
• Tol Jolien, Nagtegaal Iris D., Punt Cornelis J. A. BRAF mutation in metastatic colorectal cancer New England journal of medicine 2009;361 (1):98-99 [PubMed]
• Tol Jolien, Koopman Miriam, Cats Annemieke, Rodenburg Cees J., Creemers Geert J. M., Schrama Jolanda G., Erdkamp Frans L. G., Vos Allert H., van Groeningen Cees J., Sinnige Harm A. M., Richel Dirk J., Voest Emile E., Dijkstra Jeroen R., Vink-Börger Marianne E., Antonini Ninja F., Mol Linda, van Krieken Johan H. J. M., Dalesio Otilia, Punt Cornelis J. A. Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer New England journal of medicine 2009;360 (6):563-572 [PubMed]
• Vriens Dennis, van Laarhoven Hanneke W. M., van Asten Jack J. A., Krabbe Paul F. M., Visser Eric P., Heerschap Arend, Punt Cornelis J. A., de Geus-Oei Lioe-Fee, Oyen Wim J. G. Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate Journal of nuclear medicine 2009;50 (11):1777-1784 [PubMed]
• Koopman Miriam, Punt Cornelis J. A. Chemotherapy, which drugs and when European journal of cancer (Oxford, England 2009;45 (Suppl. 1):50-56 [PubMed]
• Fusi Alberto, Collette Sandra, Busse Antonia, Suciu Stefan, Rietz Anika, Santinami Mario, Kruit Wim H. J., Testori Alessandro, Punt Cornelis J. A., Dalgleish Angus G., Spatz Alan, Eggermont Alexander M. M., Keilholz Ulrich Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study) European journal of cancer (Oxford, England 2009;45 (18):3189-3197 [PubMed]
• Koopman M., Kortman G. A. M., Mekenkamp L., Ligtenberg M. J. L., Hoogerbrugge N., Antonini N. F., Punt C. J. A., van Krieken J. H. J. M. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer British journal of cancer 2009;100 (2):266-273 [PubMed]
• Postma C., Koopman M., Buffart T. E., Eijk P. P., Carvalho B., Peters G. J., Ylstra B., van Krieken J. H., Punt C. J. A., Meijer G. A. DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer Annals of oncology 2009;20 (6):1048-1056 [PubMed]
• Kweekel D. M., Antonini N. F., Nortier J. W. R., Punt C. J. A., Gelderblom H., Guchelaar H.-J. Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array British journal of cancer 2009;101 (2):357-362 [PubMed]
• Kweekel Dina M., Gelderblom Hans, Antonini Ninja F., van der Straaten Tahar, Nortier Johan W. R., Punt Cornelis J. A., Guchelaar Henk-Jan Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients European journal of cancer (Oxford, England 2009;45 (4):572-578 [PubMed]
• Schuurhuis Danita H., Verdijk Pauline, Schreibelt Gerty, Aarntzen Erik H. J. G., Scharenborg Nicole, de Boer Annemiek, van de Rakt Mandy W. M. M., Kerkhoff Marieke, Gerritsen Marie-Jeanne P., Eijckeler Femke, Bonenkamp Johannes J., Blokx Willeke, van Krieken J. Han, Boerman Otto C., Oyen Wim J. G., Punt Cornelis J. A., Figdor Carl G., Adema Gosse J., de Vries I. Jolanda M. In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients Cancer research 2009;69 (7):2927-2934 [PubMed]
• Verdijk Pauline, Aarntzen Erik H. J. G., Lesterhuis W. Joost, Boullart A. C. Inge, Kok Ellemieke, van Rossum Michelle M., Strijk Simon, Eijckeler Femke, Bonenkamp Johannes J., Jacobs Joannes F. M., Blokx Willeke, Vankrieken J. Han J. M., Joosten Irma, Boerman Otto C., Oyen Wim J. G., Adema Gosse, Punt Cornelis J. A., Figdor Carl G., de Vries I. Jolanda M. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients Clinical cancer research 2009;15 (7):2531-2540 [PubMed]
• Punt Cornelis J. A., Tol Jolien More is less -- combining targeted therapies in metastatic colorectal cancer Nature reviews. Clinical oncology 2009;6 (12):731-733 [PubMed]
• Kweekel D. M. Pharmacogenomics in colorectal cancer 2009. [UvA Dissertations Online] Universiteit Leiden: Geneeskunde. (Supervisors: Guchelaar H. J., Nortier J. W., Punt C. J. A.)
• Gregorc V., Santoro A., Bennicelli E., Punt C. J. A., Citterio G., Timmer-Bonte J. N. H., Caligaris Cappio F., Lambiase A., Bordignon C., van Herpen C. M. L. Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours British journal of cancer 2009;101 (2):219-224 [PubMed]
• Schuurhuis Danita H., Lesterhuis W. Joost, Kramer Matthijs, Looman Maaike G. M., van Hout-Kuijer Maaike, Schreibelt Gerty, Boullart A. C. Inge, Aarntzen Erik H. J. G., Benitez-Ribas Daniel, Figdor Carl G., Punt Cornelis J. A., de Vries I. Jolanda M., Adema Gosse J. Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells Cancer immunology, immunotherapy 2009;58 (7):1109-1115 [PubMed]
• Koopman Miriam, Venderbosch Sabine, van Tinteren Harm, Ligtenberg Marjolijn J., Nagtegaal Iris, van Krieken Johan H., Punt Cornelis J. Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study European journal of cancer (Oxford, England 2009;45 (11):1999-2006 [PubMed]
• Cohen S. J., Punt C. J. A., Iannotti N., Saidman B. H., Sabbath K. D., Gabrail N. Y., Picus J., Morse M. A., Mitchell E., Miller M. C., Doyle G. V., Tissing H., Terstappen L. W. M. M., Meropol N. J. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer Annals of oncology 2009;20 (7):1223-1229 [PubMed]
• Mannaerts L., Bleeker-Rovers C. P., Koopman M., Punt C. J. A., van Herpen C. M. L. Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: a case report Netherlands journal of medicine 2009;67 (2):69-71 [PubMed]
• Koopman Miriam, Seymour Matthew T., Punt Cornelis J. A. The CAIRO and FOCUS studies: which lesson is to be learned? oncologist 2009;14 (2):192-3; author reply 194-6 [PubMed]
• Koopman M. Towards an optimal use of chemotherapy in advanced colorectal cancer patients 2009. [UvA Dissertations Online] Radboud Universiteit Nijmegen: Geneeskunde. (Supervisors: Punt C. J. A., van Krieken J. H. J. M.)
• Jacobs Joannes F. M., Aarntzen Erik H. J. G., Sibelt Lenny A. G., Blokx Willeke A., Boullart Anna C. I., Gerritsen Marie-Jeanne, Hoogerbrugge Peter M., Figdor Carl G., Adema Gosse J., Punt Cornelis J. A., de Vries I. Jolanda M. Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients Cancer immunology, immunotherapy 2009;58 (1):145-151 [PubMed]
• Lesterhuis Willem Joost, Rennings Alexander J., Leenders William P., Nooteboom Arjan, Punt Cornelis J., Sweep Fred C., Pickkers Peter, Geurts-Moespot Anneke, van Laarhoven Hanneke W., van der Vlag Johan, Berden Jo H., Postma Cor T., van der Meer Jos W. Vascular endothelial growth factor in systemic capillary leak syndrome American journal of medicine 2009;122 (6):e5-e7 [PubMed]

2008

• Benitez-Ribas Daniel, Tacken Paul, Punt Cornelis J. A., de Vries I. Jolanda M., Figdor Carl G. Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc gammaRII-mediated uptake of immune complexes and presentation by MHC class II Journal of immunology (Baltimore, Md. 2008;181 (8):5219-5224 [PubMed]
• Eggermont Alexander M. M., Suciu Stefan, Santinami Mario, Testori Alessandro, Kruit Wim H. J., Marsden Jeremy, Punt Cornelis J. A., Salès François, Gore Martin, Mackie Rona, Kusic Zvonko, Dummer Reinhard, Hauschild Axel, Musat Elena, Spatz Alain, Keilholz Ulrich, Salès F., Baurain J. F., Vereecke P., Thomas J., Verschaeve V., Ollivaud L., Aubin F., Leccia M. T., Avril M. F., Robert C., Negrier S., Guillot B., Dereure O., Lipsker D., Delaunay M., Geoffrois L., Vilmer-Renaud C., Piette F., Lesimple T., Truchetet F., Cupissol D., Beylot-Barry M., Bedane C., Lacour J. P., Machet L., Cambazar F., Perrot J., Saiag P., Vreugdenhil G., Groenewegen G., van den Eertwegh A., Osanto S., Ortiz-Romero P. L., Castel Rodo T. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial Lancet 2008;372 (9633):117-126 [PubMed]
• Tol J., Koopman M., Rodenburg C. J., Cats A., Creemers G. J., Schrama J. G., Erdkamp F. L. G., Vos A. H., Mol L., Antonini N. F., Punt C. J. A. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity Annals of oncology 2008;19 (4):734-738 [PubMed]
• Punt Cornelis J. A., Koopman Miriam Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer Journal of clinical oncology 2008;26 (11):1907-8; author reply 1908-9 [PubMed]
• de Geus-Oei L. F., van Laarhoven H. W. M., Visser E. P., Hermsen R., van Hoorn B. A., Kamm Y. J. L., Krabbe P. F. M., Corstens F. H. M., Punt C. J. A., Oyen W. J. G. Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer Annals of oncology 2008;19 (2):348-352 [PubMed]
• Aarntzen E. H. J. G., Figdor C. G., Adema G. J., Punt C. J. A., de Vries I. J. M. Dendritic cell vaccination and immune monitoring Cancer immunology, immunotherapy 2008;57 (10):1559-1568 [PubMed]
• Lesterhuis W. J., Aarntzen E. H. J. G., de Vries I. J. M., Schuurhuis D. H., Figdor C. G., Adema G. J., Punt C. J. A. Dendritic cell vaccines in melanoma: from promise to proof? Critical reviews in oncology/hematology 2008;66 (2):118-134 [PubMed]
• Tol J., Cats A., Mol L., Koopman M., Bos M. M. E. M., van der Hoeven J. J. M., Antonini N. F., van Krieken J. H. J. M., Punt C. J. A. Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation Investigational new drugs 2008;26 (4):393-397 [PubMed]
• Kweekel D. M., Koopman M., Antonini N. F., van der Straaten T., Nortier J. W. R., Gelderblom H., Punt C. J. A., Guchelaar H.-J. GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group British journal of cancer 2008;99 (8):1316-1321 [PubMed]
• Schouten van der Velden A. P., Punt C. J. A., van Krieken J. H. J., Derleyn V. A., Ruers T. J. M. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month European journal of surgical oncology 2008;34 (3):353-355 [PubMed]
• Boullart A. C. Inge, Aarntzen Erik H. J. G., Verdijk Pauline, Jacobs Joannes F. M., Schuurhuis Danita H., Benitez-Ribas Daniel, Schreibelt Gerty, van de Rakt Mandy W. M. M., Scharenborg Nicole M., de Boer Annemiek, Kramer Matthijs, Figdor Carl G., Punt Cornelis J. A., Adema Gosse J., de Vries I. Jolanda M. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration Cancer immunology, immunotherapy 2008;57 (11):1589-1597 [PubMed]
• Verdijk Pauline, Aarntzen Erik H. J. G., Punt Cornelis J. A., de Vries I. Jolanda M., Figdor Carl G. Maximizing dendritic cell migration in cancer immunotherapy Expert opinion on biological therapy 2008;8 (7):865-874 [PubMed]
• Timmer-Bonte J. N. H., Punt C. J. A., vd Heijden H. F. M., van Die C. E., Bussink J., Beijnen J. H., Huitema A. D. R., Tjan-Heijnen V. C. G. Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer Lung cancer (Amsterdam, Netherlands) 2008;60 (2):222-230 [PubMed]
• Cohen Steven J., Punt Cornelis J. A., Iannotti Nicholas, Saidman Bruce H., Sabbath Kert D., Gabrail Nashat Y., Picus Joel, Morse Michael, Mitchell Edith, Miller M. Craig, Doyle Gerald V., Tissing Henk, Terstappen Leon W. M. M., Meropol Neal J. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer Journal of clinical oncology 2008;26 (19):3213-3221 [PubMed]
• Koopman Miriam, Muller Erik W., Punt Cornelis J. A. Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case Diseases of the colon and rectum 2008;51 (9):1425-1426 [PubMed]
• Meyer-Wentrup Friederike, Benitez-Ribas Daniel, Tacken Paul J., Punt Cornelis J. A., Figdor Carl G., de Vries I. Jolanda M., Adema Gosse J. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production Blood 2008;111 (8):4245-4253 [PubMed]
• Kweekel D. M., Gelderblom H., van der Straaten T., Antonini N. F., Punt C. J. A., Guchelaar H.-J., van der Hoeven J., Richel D., de Valk B., Douma J., Nieboer P., Valster F., Ras G., Loosveld O., Kehrer D., Bos M., Sinnige H., Knibbeler C., van Deijk W., Sleeboom H., Muller E., Balk E., Creemers G., de Jong R., Zoon P., Wals J., Polee M., Tesselaar M., Brouwer R., de Jong P., Slee P., Oosten H., Kuper M., den Boer M., de Jongh F., Veldhuis G., ten Bokkel Huinink D., van Bochove A. UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study British journal of cancer 2008;99 (2):275-282 [PubMed]

2007

• Krol Marieke, Koopman Miriam, Uyl-de Groot Carin, Punt Cornelis J. A. A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer Expert opinion on pharmacotherapy 2007;8 (9):1313-1328 [PubMed]
• Seymour Matthew T., Punt Cornelis J. A. CAIRO and FOCUS Lancet 2007;370 (9603):1904-5; author reply 1905 [PubMed]
• Blokx Willeke A. M., Lesterhuis W. Joost, Andriessen Monique P. M., Verdijk Marian A. J., Punt Cornelis J. A., Ligtenberg Marjolijn J. L. CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma American journal of surgical pathology 2007;31 (4):637-641 [PubMed]
• Ruers Theo J. M., Joosten Joris J., Wiering Bastiaan, Langenhoff Barbara S., Dekker Heleen M., Wobbes Theo, Oyen Wim J. G., Krabbe Paul F. M., Punt Cornelis J. A. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study Annals of surgical oncology 2007;14 (3):1161-1169 [PubMed]
• Punt Cornelis J. A., Buyse Marc, Köhne Claus-Henning, Hohenberger Peter, Labianca Roberto, Schmoll Hans J., Påhlman Lars, Sobrero Alberto, Douillard Jean-Yves Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials Journal of the National Cancer Institute 2007;99 (13):998-1003 [PubMed]
• de Vries I. J. M., Bernsen M. R., van Geloof W. L., Scharenborg N. M., Lesterhuis W. J., Rombout P. D. M., van Muijen G. N. P., Figdor C. G., Punt C. J. A., Ruiter D. J., Adema G. J. In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients Cancer immunology, immunotherapy 2007;56 (10):1667-1676 [PubMed]
• van Laarhoven H. W. M., Klomp D. W. J., Rijpkema M., Kamm Y. L. M., Wagener D. J. Th, Barentsz J. O., Punt C. J. A., Heerschap A. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil NMR in biomedicine 2007;20 (2):128-140 [PubMed]
• Hospers Geke A., Punt Cornelis J. A., Tesselaar Margot E., Cats Annemieke, Havenga Klaas, Leer Jan W. H., Marijnen Corrie A., Jansen Edwin P., van Krieken Han H. J. M., Wiggers Theo, van de Velde Cornelis J. H., Mulder Nanno H. Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group Annals of surgical oncology 2007;14 (10):2773-2779 [PubMed]
• Schmidt Henrik, Suciu Stefan, Punt Cornelis J. A., Gore Martin, Kruit Wim, Patel Poulam, Lienard Danielle, von der Maase Hans, Eggermont Alexander M. M., Keilholz Ulrich Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial Journal of clinical oncology 2007;25 (12):1562-1569 [PubMed]
• Verdijk Pauline, Scheenen Tom W. J., Lesterhuis W. Joost, Gambarota Giulio, Veltien Andor A., Walczak Piotr, Scharenborg Nicole M., Bulte Jeff W. M., Punt Cornelis J. A., Heerschap Arend, Figdor Carl G., de Vries I. Jolanda M. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines International journal of cancer. Journal international du cancer 2007;120 (5):978-984 [PubMed]
• Koopman Miriam, Antonini Ninja F., Douma Joep, Wals Jaap, Honkoop Aafke H., Erdkamp Frans L. G., de Jong Robert S., Rodenburg Cees J., Vreugdenhil Gerard, Loosveld Olaf J. L., van Bochove Aart, Sinnige Harm A. M., Creemers Geert-Jan M., Tesselaar Margot E. T., Slee Peter H. Th J., Werter Marjon J. B. P., Mol Linda, Dalesio Otilia, Punt Cornelis J. A. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial Lancet 2007;370 (9582):135-142 [PubMed]

2006

• Gambarota Giulio, van Laarhoven Hanneke W. M., Philippens Marielle, Lok Jasper, van der Kogel Albert, Punt Cornelius J. A., Heerschap Arend Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI Magnetic resonance imaging 2006;24 (3):279-286 [PubMed]
• van Laarhoven Hanneke W. M., Gambarota Giulio, Lok Jasper, Lammens Martin, Kamm Yvonne L. M., Wagener Theo, Punt Cornelis J. A., van der Kogel Albert J., Heerschap Arend Carbogen breathing differentially enhances blood plasma volume and 5-fluorouracil uptake in two murine colon tumor models with a distinct vascular structure Neoplasia (New York, N.Y.) 2006;8 (6):477-487 [PubMed]
• Punt C. J. A., Suciu S., Gore M. A., Koller J., Kruit W. H. J., Thomas J., Patel P., Lienard D., Eggermont A. M. M., Keilholz U. Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group European journal of cancer (Oxford, England 2006;42 (17):2991-2995 [PubMed]
• van Laarhoven H. W. M., Gambarota G., Heerschap A., Lok J., Verhagen I., Corti A., Toma S., Gallo Stampino C., van der Kogel A., Punt C. J. A. Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas Investigational new drugs 2006;24 (1):27-36 [PubMed]
• de Geus-Oei L. F., Wiering B., Krabbe P. F. M., Ruers T. J. M., Punt C. J. A., Oyen W. J. G. FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma Annals of oncology 2006;17 (11):1650-1655 [PubMed]
• de Geus-Oei Lioe-Fee, Ruers Theo J. M., Punt Cornelis J. A., Leer Jan Willem, Corstens Frans H. M., Oyen Wim J. G. FDG-PET in colorectal cancer Cancer imaging 2006;6:S71-S81 [PubMed]
• van Laarhoven Hanneke W. M., Kaanders Johannes H. A. M., Lok Jasper, Peeters Wenny J. M., Rijken Paul F. J. W., Wiering Bastiaan, Ruers Theo J. M., Punt Cornelis J. A., Heerschap Arend, van der Kogel Albert J. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer International journal of radiation oncology, biology, physics 2006;64 (2):473-482 [PubMed]
• de Jonge M. J. A., Dumez H., Verweij J., Yarkoni S., Snyder D., Lacombe D., Marréaud S., Yamaguchi T., Punt C. J. A., van Oosterom A. Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours European journal of cancer (Oxford, England 2006;42 (12):1768-1774 [PubMed]
• Benitez-Ribas Daniel, Adema Gosse J., Winkels Gregor, Klasen Ina S., Punt Cornelis J. A., Figdor Carl G., de Vries I. Jolanda M. Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake Journal of experimental medicine 2006;203 (7):1629-1635 [PubMed]
• Koopman M., Antonini N. F., Douma J., Wals J., Honkoop A. H., Erdkamp F. L. G., de Jong R. S., Rodenburg C. J., Vreugdenhil G., Akkermans-Vogelaar J. M., Punt C. J. A. Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study Annals of oncology 2006;17 (10):1523-1528 [PubMed]
• van den Berkmortel F., Gidding C., de Kanter M., Punt C. J. A. Severe encephalopathy after high-dose chemotherapy with autologous stem cell support for brain tumours Anticancer research 2006;26 (1B):729-733 [PubMed]
• Hendrickx Baudewijn W., Punt Cees J. A., Boerman Otto C., Postema Ernst J., Oosterwijk Egbert, Mavridu Agapi, Corstens Frans H. M., Oyen Wim J. G. Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250 Cancer biotherapy & radiopharmaceuticals 2006;21 (3):263-268 [PubMed]
• Tol J., Punt C. J. A. Treatment of liver metastases from colorectal cancer Netherlands journal of medicine 2006;64 (5):133-135 [PubMed]
• Lesterhuis W. J., de Vries I. J. M., Schuurhuis D. H., Boullart A. C. I., Jacobs J. F. M., de Boer A. J., Scharenborg N. M., Brouwer H. M. H., van de Rakt M. W. M. M., Figdor C. G., Ruers T. J., Adema G. J., Punt C. J. A. Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests Annals of oncology 2006;17 (6):974-980 [PubMed]

2005

• Rea D. W., Nortier J. W. R., ten Bokkel Huinink W. W., Falk S., Richel D. J., Maughan T., Groenewegen G., Smit J. M., Steven N., Bakker J. M., Semiond D., Kerr D. J., Punt C. J. A. A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer Annals of oncology 2005;16 (7):1123-1132 [PubMed]
• Keilholz Ulrich, Punt Cornelis J. A., Gore Martin, Kruit Wim, Patel Poulam, Lienard Danielle, Thomas Jose, Proebstle Thomas M., Schmittel Alexander, Schadendorf Dirk, Velu Thierry, Negrier Sylvie, Kleeberg Ulrich, Lehman Frederic, Suciu Stefan, Eggermont Alexander M. M. Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group Journal of clinical oncology 2005;23 (27):6747-6755 [PubMed]
• Tacken Paul J., de Vries I. Jolanda M., Gijzen Karlijn, Joosten Ben, Wu Dayang, Rother Russell P., Faas Susan J., Punt Cornelis J. A., Torensma Ruurd, Adema Gosse J., Figdor Carl G. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody Blood 2005;106 (4):1278-1285 [PubMed]
• van Laarhoven Hanneke W. M., de Geus-Oei Lioe-Fee, Wiering Bastiaan, Lok Jasper, Rijpkema Mark, Kaanders Johannes H. A. M., Krabbe Paul F. M., Ruers Theo, Punt Cornelis J. A., van der Kogel Albert J., Oyen Wim J. G., Heerschap Arend Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET Radiology 2005;237 (1):181-188 [PubMed]
• de Vries I. Jolanda M., Bernsen Monique R., Lesterhuis W. Joost, Scharenborg Nicole M., Strijk Simon P., Gerritsen Marie-Jeanne P., Ruiter Dirk J., Figdor Carl G., Punt Cornelis J. A., Adema Gosse J. Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome Journal of clinical oncology 2005;23 (24):5779-5787 [PubMed]
• Punt C. J. A. Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer? Annals of oncology 2005;16 (6):845-846 [PubMed]
• de Vries I. Jolanda M., Lesterhuis W. Joost, Barentsz Jelle O., Verdijk Pauline, van Krieken J. Han, Boerman Otto C., Oyen Wim J. G., Bonenkamp Johannes J., Boezeman Jan B., Adema Gosse J., Bulte Jeff W. M., Scheenen Tom W. J., Punt Cornelis J. A., Heerschap Arend, Figdor Carl G. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy Nature biotechnology 2005;23 (11):1407-1413 [PubMed]
• Punt C. J. A. Medicamenteuze behandeling van patiënten met colorectumcarcinoom Nederlands tijdschrift voor geneeskunde 2005;149 (26):1441-1447 [PubMed]
• Adema Gosse J., de Vries I. Jolanda M., Punt Cornelis J. A., Figdor Carl G. Migration of dendritic cell based cancer vaccines: in vivo veritas? Current opinion in immunology 2005;17 (2):170-174 [PubMed]
• van Laarhoven H. W. M., Bussink J., Lok J., Verhagen I., Punt C. J. A., Heerschap A., Kaanders J. H. A. M., van der Kogel A. J. Modulation of hypoxia in murine liver metastases of colon carcinoma by nicotinamide and carbogen Radiation research 2005;164 (3):245-249 [PubMed]
• van Laarhoven Hanneke W. M., Punt Cornelis J. A., Kamm Yvonne J. L., Heerschap Arend Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy Critical reviews in oncology/hematology 2005;56 (3):321-343 [PubMed]
• Smyth J. F., Aamdal S., Awada A., Dittrich C., Caponigro F., Schöffski P., Gore M., Lesimple T., Djurasinovic N., Baron B., Ravic M., Fumoleau P., Punt C. J. A. Phase II study of E7070 in patients with metastatic melanoma Annals of oncology 2005;16 (1):158-161 [PubMed]
• de Vries I. Jolanda M., Adema Gosse J., Punt Cornelis J. A., Figdor Carl G. Phenotypical and functional characterization of clinical-grade dendritic cells Methods in molecular medicine 2005;109:113-126 [PubMed]
• Eggermont Alexander M. M., Suciu Stefan, Mackie Rona, Ruka Wlodzimierz, Testori Alessandro, Kruit Wim, Punt Cornelis J. A., Delauney Michelle, Sales François, Groenewegen Gerard, Ruiter Dirk J., Jagiello Izabella, Stoitchkov Konstantin, Keilholz Ulrich, Lienard Danielle Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial Lancet 2005;366 (9492):1189-1196 [PubMed]
• van Kesteren Charlotte, Zandvliet Anthe S., Karlsson Mats O., Mathôt Ron A. A., Punt Cornelis J. A., Armand Jean-Pierre, Raymond Eric, Huitema Alwin D. R., Dittrich Christian, Dumez Herlinde, Roché Henri H., Droz Jean-Pierre, Ravic Miroslav, Yule S. Murray, Wanders Jantien, Beijnen Jos H., Fumoleau Pierre, Schellens Jan H. M. Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam Investigational new drugs 2005;23 (3):225-234 [PubMed]

2004

• Lesterhuis W. J., de Vries I. J. M., Adema G. J., Punt C. J. A. Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results Annals of oncology 2004;15 (Suppl. 4):iv145-iv151 [PubMed]
• van Laarhoven Hanneke W. M., Bussink Johan, Lok Jasper, Punt Cornelis J. A., Heerschap Arend, van der Kogel Albert J. Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters International journal of radiation oncology, biology, physics 2004;60 (1):310-321 [PubMed]
• Punt C. J. A. New options and old dilemmas in the treatment of patients with advanced colorectal cancer Annals of oncology 2004;15 (10):1453-1459 [PubMed]
• Bernsen Monique R., Diepstra J. Heleen S., van Mil Patrick, Punt Cornelis J. A., Figdor Carl G., van Muijen Goos N. P., Adema Gosse J., Ruiter Dirk J. Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells Journal of pathology 2004;202 (1):70-79 [PubMed]
• Punt C. J. A., de Jonge M. J. A., Monfardini S., Daugaard G., Fiedler W., Baron B., Lacombe D., Fumoleau P. RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group European journal of cancer (Oxford, England 2004;40 (9):1332-1334 [PubMed]
• van Laarhoven Hanneke W. M., Punt Cornelis J. A. Systemic treatment of advanced colorectal carcinoma European journal of gastroenterology & hepatology 2004;16 (3):283-289 [PubMed]

2003

• van Laarhoven Hanneke W. M., Verstappen Carla C. P., Beex Louk V. A. M., Kappelle Arnoud C., Punt Cornelis J. A. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug Anticancer research 2003;23 (1B):647-648 [PubMed]
• Eggert Andreas A. O., van der Voort Robbert, Torensma Ruurd, Moulin Veronique, Boerman Otto C., Oyen Wim J. G., Punt C. J. A., Diepstra Heleen, de Boer Annemiek J., Figdor Carl G., Adema Gosse J. Analysis of dendritic cell trafficking using EGFP-transgenic mice Immunology letters 2003;89 (1):17-24 [PubMed]
• O'Donnell Anne, Punt Cornelis J. A., Judson Ian, van Maanen Lydia, Suttle A. Benjamin, Ertel Philip, Beale Philip A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005) Cancer chemotherapy and pharmacology 2003;51 (1):58-66 [PubMed]
• Kamm Y. J. L., Peters G. J., Hull W. E., Punt C. J. A., Heerschap A. Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma British journal of cancer 2003;89 (4):754-762 [PubMed]
• Vlems F. A., Wobbes Th, Punt C. J. A., van Muijen G. N. P. Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer Anticancer research 2003;23 (1B):523-530 [PubMed]
• Vlems F. A., Diepstra J. H. S., Punt C. J. A., Ligtenberg M. J. L., Cornelissen I. M. H. A., van Krieken J. H. J. M., Wobbes T., van Muijen G. N. P., Ruers T. J. M. Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer British journal of surgery 2003;90 (8):989-995 [PubMed]
• Eggermont Alexander M. M., Punt Cornelis J. A. Does adjuvant systemic therapy with interferon-alpha for stage II-III melanoma prolong survival? American journal of clinical dermatology 2003;4 (8):531-536 [PubMed]
• de Vries I. Jolanda M., Krooshoop Daniëlle J. E. B., Scharenborg Nicole M., Lesterhuis W. Joost, Diepstra J. Heleen S., van Muijen Goos N. P., Strijk Simon P., Ruers Theo J., Boerman Otto C., Oyen Wim J. G., Adema Gosse J., Punt Cornelis J. A., Figdor Carl G. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state Cancer research 2003;63 (1):12-17 [PubMed]
• Marchand M., Punt C. J. A., Aamdal S., Escudier B., Kruit W. H. J., Keilholz U., Håkansson L., van Baren N., Humblet Y., Mulders P., Avril M.-F., Eggermont A. M. M., Scheibenbogen C., Uiters J., Wanders J., Delire M., Boon T., Stoter G. Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report European journal of cancer (Oxford, England 2003;39 (1):70-77 [PubMed]
• Vlems F. A., Diepstra J. H. S., Cornelissen I. M. H. A., Ligtenberg M. J. L., Wobbes Th, Punt C. J. A., van Krieken J. H. J. M., Ruers T. J. M., van Muijen G. N. P. Investigations for a multi-marker RT-PCR to improve sensitivity of disseminated tumor cell detection Anticancer research 2003;23 (1A):179-186 [PubMed]
• van Laarhoven Hanneke W. M., Klomp Dennis W. J., Kamm Yvonne J. L., Punt Cornelis J. A., Heerschap Arend In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength Cancer research 2003;63 (22):7609-7612 [PubMed]
• de Vries I. Jolanda M., Lesterhuis W. Joost, Scharenborg Nicole M., Engelen Linda P. H., Ruiter Dirk J., Gerritsen Marie-Jeanne P., Croockewit Sandra, Britten Cedrik M., Torensma Ruurd, Adema Gosse J., Figdor Carl G., Punt Cornelis J. A. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients Clinical cancer research 2003;9 (14):5091-5100 [PubMed]
• van Laarhoven Hanneke W. M., Rijpkema Mark, Punt Cornelis J. A., Ruers Theo J., Hendriks Jan C. M., Barentsz Jelle O., Heerschap Arend Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases Journal of magnetic resonance imaging 2003;18 (3):315-320 [PubMed]
• Punt C. J. A., Boni J., Bruntsch U., Peters M., Thielert C. Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors Annals of oncology 2003;14 (6):931-937 [PubMed]
• Vlems F. A., Ruers T. J. M., Punt C. J. A., Wobbes Th, van Muijen G. N. P. Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective European journal of surgical oncology 2003;29 (4):289-302 [PubMed]
• Punt C. J. A. Statistical trial designs and clinical practice: are they compatible? Onkologie 2003;26 (6):518-519 [PubMed]

2002

• Giaccone Giuseppe, Punt Cornelis J. A., Ando Yoshitaka, Ruijter Rita, Nishi Nobusuke, Peters Marlies, von Blomberg B. Mary E., Scheper Rik J., van der Vliet Hans J. J., van den Eertwegh Alfons J. M., Roelvink Marja, Beijnen Jos, Zwierzina Heinz, Pinedo Herbert M. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors Clinical cancer research 2002;8 (12):3702-3709 [PubMed]
• de Kleijn E. M. H. A., Punt C. J. A. Biological therapy of colorectal cancer European journal of cancer (Oxford, England 2002;38 (7):1016-1022 [PubMed]
• Gijtenbeek J. M. M., van Eck A. T. C. J., van der Maazen R. W. M., Koetsveld A. C., Punt C. J. A. De behandeling van hersenmetastasen Nederlands tijdschrift voor geneeskunde 2002;146 (37):1724-1729 [PubMed]
• van Kesteren Charlotte, Mathôt R. A. A., Raymond E., Armand J. P., Fumoleau P., Punt C., Ravic M., Wanders J., Beijnen J. H., Schellens J. H. M. Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide) British journal of clinical pharmacology 2002;54 (5):463-471 [PubMed]
• Punt Cornelis J. A., Nagy Attila, Douillard Jean-Yves, Figer Arie, Skovsgaard Torben, Monson John, Barone Carlo, Fountzilas George, Riess Hanno, Moylan Eugene, Jones Delyth, Dethling Juergen, Colman Jessica, Coward Lorna, Macgregor Stuart Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study Lancet 2002;360 (9334):671-677 [PubMed]
• Punt C. J. A., Blanke C. D., Zhang J., Hammershaimb L. Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer Annals of oncology 2002;13 (1):92-94 [PubMed]
• Vlems F. A., Diepstra J. H. S., Cornelissen I. M. H. A., Ruers T. J. M., Ligtenberg M. J. L., Punt C. J. A., van Krieken J. H. J. M., Wobbes Th, van Muijen G. N. P. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue Molecular pathology 2002;55 (3):156-163 [PubMed]
• Punt C. J. A. Performing phase III clinical trials: never an easy task Onkologie 2002;25 (5):402-403 [PubMed]
• de Jonge Maja J. A., Punt Cornelis J. A., Sparreboom Alex, Planting André S. T., Peters M. E. W. J., van de Schraaf Jacqueline, Jackman Ann, Smith Rob, de Mulder Pieter H. M., Verweij Jaap Phase I and pharmacologic study of oral ZD9331, a novel nonpolyglutamated thymidylate synthase inhibitor, in adult patients with solid tumors Journal of clinical oncology 2002;20 (7):1923-1931 [PubMed]
• de Vries I. Jolanda M., Eggert Andreas A. O., Scharenborg Nicole M., Vissers Joost L. M., Lesterhuis W. Joost, Boerman Otto C., Punt Cornelis J. A., Adema Gosse J., Figdor Carl G. Phenotypical and functional characterization of clinical grade dendritic cells Journal of immunotherapy (Hagerstown, Md. 2002;25 (5):429-438 [PubMed]
• van Kesteren Ch, Mathôt R. A. A., Raymond E., Armand J. P., Dittrich Ch, Dumez H., Roché H., Droz J. P., Punt C., Ravic M., Wanders J., Beijnen J. H., Fumoleau P., Schellens J. H. M. Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation Journal of clinical oncology 2002;20 (19):4065-4073 [PubMed]
• Crul Mirjam, Mathôt Ron A., Giaccone Giuseppe, Punt Cornelis A., Rosing Hilde, Hillebrand Michel X., Ando Yoshitaka, Nishi Nobosuke, Tanaka Hideji, Schellens Jan M., Beijnen Jos H. Population pharmacokinetics of the novel anticancer agent KRN7000 Cancer chemotherapy and pharmacology 2002;49 (4):287-293 [PubMed]
• Keilholz U., Martus P., Punt C. J. A., Kruit W., Mooser G., Schadendorf D., Liénard D., Dummer R., Koller J., Voit C., Eggermont A. M. M. Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin European journal of cancer (Oxford, England 2002;38 (11):1501-1511 [PubMed]
• Koolen D. A., van Laarhoven H. W. M., Wobbes Th, Punt C. J. A. Single-centre experience with tunnelled central venous catheters in 150 cancer patients Netherlands journal of medicine 2002;60 (10):397-401 [PubMed]
• Punt C. J. A., Keizer H. J., Douma J., Skovsgaard T., Schüller J., Muller E. W., ten Napel C. H. H., Croles J. J., Lochs H., Zhang J., Hammershaimb L. Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study Annals of oncology 2002;13 (1):81-86 [PubMed]

2001

• Punt C. J., Eggermont A. M. Adjuvant interferon-alpha for melanoma revisited: news from old and new studies Annals of oncology 2001;12 (12):1663-1666 [PubMed]
• Punt C. J., Fumoleau P., van de Walle B., Faber M. N., Ravic M., Campone M. Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG) Annals of oncology 2001;12 (9):1289-1293 [PubMed]
• Punt C. J., van Maanen L., Bol C. J., Seifert W. F., Wagener D. J. Phase I and pharmacokinetic study of the orally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors Anti-cancer drugs 2001;12 (3):193-197 [PubMed]
• Ruiter D. J., Testori A., Eggermont A. M., Punt C. J. The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group Annals of oncology 2001;12 (1):9-11 [PubMed]

2000

• de Vries T. J., Fourkour A., Punt C. J., Ruiter D. J., van Muijen G. N. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method Melanoma research 2000;10 (2):119-126 [PubMed]
• Schreurs M. W., Eggert A. A., Punt C. J., Figdor C. G., Adema G. J. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy Critical reviews in oncogenesis 2000;11 (1):1-17 [PubMed]
• Punt C. J. 'Hold the Mayo': solid facts or pulp fiction? Annals of oncology 2000;11 (8):919-920 [PubMed]
• Groenewegen G., Osanto S., van der Rhee H. J., Punt C. J. Interferon als adjuvante therapie bij het melanoom: wel geregistreerd, niet geïndiceerd Nederlands tijdschrift voor geneeskunde 2000;144 (45):2160-2162 [PubMed]
• Punt C. J. Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer Seminars in oncology 2000;27 (5 Suppl 10):88-90 [PubMed]

1999

• Eggert A. A., Schreurs M. W., Boerman O. C., Oyen W. J., de Boer A. J., Punt C. J., Figdor C. G., Adema G. J. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration Cancer research 1999;59 (14):3340-3345 [PubMed]
• van Cutsem E., Cunningham D., ten Bokkel Huinink W. W., Punt C. J., Alexopoulos C. G., Dirix L., Symann M., Blijham G. H., Cholet P., Fillet G., van Groeningen C., Vannetzel J. M., Levi F., Panagos G., Unger C., Wils J., Cote C., Blanc C., Hérait P., Bleiberg H. Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU) European journal of cancer (Oxford, England 1999;35 (1):54-59 [PubMed]
• Punt C. J., de Vries I. J., Mulders P. F., Adema G. J., Figdor C. G. Immunologie in de medische praktijk. XXV. Toepassing van dendritische cellen in de immunotherapie van kanker Nederlands tijdschrift voor geneeskunde 1999;143 (48):2408-2414 [PubMed]
• de Vries T. J., Fourkour A., Punt C. J., Diepstra H., Ruiter D. J., van Muijen G. N. Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood British journal of cancer 1999;81 (6):1066-1070 [PubMed]
• de Jonge M. J., Punt C. J., Gelderblom A. H., Loos W. J., van Beurden V., Planting A. S., van der Burg M. E., van Maanen L. W., Dallaire B. K., Verweij J., Wagener D. J., Sparreboom A. Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumors Journal of clinical oncology 1999;17 (7):2219-2226 [PubMed]
• Awada A., Punt C. J., Piccart M. J., van Tellingen O., van Manen L., Kerger J., Groot Y., Wanders J., Verweij J., Wagener D. J. Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule British journal of cancer 1999;79 (9-10):1454-1461 [PubMed]
• Sparreboom A., de Jonge M. J., Punt C. J., Loos W. J., Nooter K., Stoter G., Porro M. G., Verweij J. Prediction of the systemic exposure to oral 9-amino-20(S)-camptothecin using single-sample analysis Drug metabolism and disposition: the biological fate of chemicals 1999;27 (7):816-820 [PubMed]
• de Vries T. J., Fourkour A., Punt C. J., van de Locht L. T., Wobbes T., van den Bosch S., de Rooij M. J., Mensink E. J., Ruiter D. J., van Muijen G. N. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR British journal of cancer 1999;80 (5-6):883-891 [PubMed]

1998

• Kamm Y. J., Wagener D. J., Rietjens I. M., Punt C. J. 5-Fluorouracil in colorectal cancer: rationale and clinical results of frequently used schedules Anti-cancer drugs 1998;9 (5):371-380 [PubMed]
• van Tellingen O., Punt C. J., Awada A., Wagener D. J., Piccart M. J., Groot Y., Schaaf L. J., Henrar R. E., Nooijen W. J., Beijnen J. H. A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study Cancer chemotherapy and pharmacology 1998;41 (5):377-384 [PubMed]
• Punt C. J. New drugs in the treatment of colorectal carcinoma Cancer 1998;83 (4):679-689 [PubMed]
• Sparreboom A., de Jonge M. J., Punt C. J., Nooter K., Loos W. J., Porro M. G., Verweij J. Pharmacokinetics and bioavailability of oral 9-aminocamptothecin capsules in adult patients with solid tumors Clinical cancer research 1998;4 (8):1915-1919 [PubMed]
• Cunningham D., Pyrhönen S., James R. D., Punt C. J., Hickish T. F., Heikkila R., Johannesen T. B., Starkhammar H., Topham C. A., Awad L., Jacques C., Herait P. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Lancet 1998;352 (9138):1413-1418 [PubMed]
• van den Bent M. J., Kros J. M., Heimans J. J., Pronk L. C., van Groeningen C. J., Krouwer H. G., Taphoorn M. J., Zonnenberg B. A., Tijssen C. C., Twijnstra A., Punt C. J., Boogerd W. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group Neurology 1998;51 (4):1140-1145 [PubMed]
• Keilholz U., Conradt C., Legha S. S., Khayat D., Scheibenbogen C., Thatcher N., Goey S. H., Gore M., Dorval T., Hancock B., Punt C. J., Dummer R., Avril M. F., Bröcker E. B., Benhammouda A., Eggermont A. M., Pritsch M. Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients Journal of clinical oncology 1998;16 (9):2921-2929 [PubMed]
• Punt C. J. The use of interferon-alpha in the treatment of cutaneous melanoma: a review Melanoma research 1998;8 (2):95-104 [PubMed]

1997

• van Halteren H. K., Wagener D. J., Vreugdenhil G., Punt C. J. Advanced colorectal cancer, refractory to infusional fluorouracil treatment: efficacy of second line fluorouracil in combination with a different biochemical modulation Anticancer research 1997;17 (4A):2715-2719 [PubMed]
• Punt C. J., van Herpen C. M., Jansen R. L., Vreugdenhil G., Muller E. W., de Mulder P. H. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study British journal of cancer 1997;76 (2):266-269 [PubMed]
• Keilholz U., Goey S. H., Punt C. J., Proebstle T. M., Salzmann R., Scheibenbogen C., Schadendorf D., Liénard D., Enk A., Dummer R., Hantich B., Geueke A. M., Eggermont A. M. Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group Journal of clinical oncology 1997;15 (7):2579-2588 [PubMed]
• Punt C. J., Voest E. E., Tueni E., van Oosterom A. T., Backx A., de Mulder P. H., Hecquet B., Lucas C., Gerard B., Bleiberg H. Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer British journal of cancer 1997;76 (10):1376-1381 [PubMed]
• Keilholz U., Stoter G., Punt C. J., Scheibenbogen C., Lejeune F., Eggermont A. M. Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group cancer journal from Scientific American 1997;3 (Suppl. 1):S22-S28 [PubMed]
• Punt C. J., Kamm Y. L., Wagener D. J. Weekly chronomodulated 48 h infusion of high-dose 5-fluorouracil modulated by methotrexate and (6S)-leucovorin in advanced colorectal cancer: a phase IB study Anti-cancer drugs 1997;8 (5):454-458 [PubMed]

1996

• Kruit W. H., Punt C. J., Goey S. H., de Mulder P. H., Gratama J. W., Eggermont A. M., Bolhuis R. L., Stoter G. Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma British journal of cancer 1996;74 (6):951-955 [PubMed]
• Punt C. J., Humblet Y., Roca E., Dirix L. Y., Wainstein R., Polli A., Corradino I. Tallimustine in advanced previously untreated colorectal cancer, a phase II study British journal of cancer 1996;73 (6):803-804 [PubMed]
• Eskens F. A., Punt C. J., Verhagen C. A. Trombo-embolische complicaties van centraal-veneuze katheters Nederlands tijdschrift voor geneeskunde 1996;140 (46):2302 [PubMed]

1995

• Punt C. J., Tytgat J. H., van Liessum P. A., Gerard B. Fotemustine and tamoxifen combination therapy in metastatic malignant melanoma. A phase II study European journal of cancer (Oxford, England 1995;31A (3):421-422 [PubMed]
• Goey S. H., Eggermont A. M., Punt C. J., Slingerland R., Gratama J. W., Oosterom R., Oskam R., Bolhuis R. L., Stoter G. Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study British journal of cancer 1995;72 (5):1283-1288 [PubMed]
• van Herpen C. M., van Hoesel Q. G., Punt C. J. Paclitaxel-induced severe hypersensitivity reaction occurring as a late toxicity Annals of oncology 1995;6 (8):852 [PubMed]
• Punt C. J., Strijk S., van der Hoeven J. J., van de Sluis R., Verhagen C. A. Spontaneous fracture of implanted central venous catheters in cancer patients: report of two cases and retrospective analysis of the 'pinch-off sign' as a risk factor Anti-cancer drugs 1995;6 (4):594-598 [PubMed]

1994

• Punt C. J., Barbuto J. A., Zhang H., Grimes W. J., Hatch K. D., Hersh E. M. Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes Cancer immunology, immunotherapy 1994;38 (4):225-232 [PubMed]
• Wagener D. J., Punt C. J., Wilke H. Current status and future directions in the perioperative treatment of pancreatic cancer Annals of oncology 1994;5 (Suppl. 3):87-90 [PubMed]
• Punt C. J., Kingma B. J. Severe asthenia and fatigue caused by recombinant human granulocyte colony-stimulating factor (rh G-CSF) Annals of oncology 1994;5 (5):473 [PubMed]

1993

• Punt C. J., Burghouts J. T., Croles J. J., van Liessum P. A., de Mulder P. H., Kamm Y. Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study Cancer 1993;72 (7):2107-2111 [PubMed]

1992

• Punt C. J., de Mulder P. H., Burghouts J. T., Wagener D. J. Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study Cancer chemotherapy and pharmacology 1992;29 (4):326-328 [PubMed]
• Punt C. J., de Mulder P. H., Burghouts J. T., Wagener D. J. Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer Seminars in oncology 1992;19 (2 Suppl 3):208-210 [PubMed]
• Punt C. J., Rijksen G., van Oirschot B. A., Kester-Schipper G. P., van der Heijden M. C., Dekker A. W., Staal G. E. Partial characterization of protein tyrosine kinases in human lymphoid cells Anticancer research 1992;12 (6B):2075-2084 [PubMed]
• Punt C. J. Regulation of hematopoietic cell function by protein tyrosine kinase-encoding oncogenes, a review Leukemia research 1992;16 (6-7):551-559 [PubMed]

1991

• Punt C. J., Rijksen G., Vlug A. M., van der Heijden M. C., Dekker A. W., Staal G. E. Partial characterization of protein tyrosine kinase activity in normal and leukemic human myeloid cells Leukemia research 1991;15 (12):1107-1116 [PubMed]

1990

• Vecht C. J., Keohane C., Menon R. S., Punt C. J., Stoter G. Acute fatal leukoencephalopathy after interleukin-2 therapy New England journal of medicine 1990;323 (16):1146-1147 [PubMed]
• Punt C. J., Henzen-Logmans S. C., Bolhuis R. L., Stoter G. Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2) British journal of cancer 1990;61 (3):491 [PubMed]

1989

• Punt C. J., Rijksen G., Vlug A. M., Dekker A. W., Staal G. E. Tyrosine protein kinase activity in normal and leukaemic human blood cells British journal of haematology 1989;73 (1):51-56 [PubMed]

1987

• Punt C. J., Rozenberg-Arska M., Verdonck L. F. Successful treatment with chemotherapy and subsequent allogeneic bone marrow transplantation for myeloid blastic crisis of chronic myelogenous leukemia following advanced Hodgkin's disease Cancer 1987;60 (5):934-935 [PubMed]

1985

• Punt C. J., de Hooge P., Hoekstra J. B. False-positive subtraction scintigram of the parathyroid glands due to metastatic tumor Journal of nuclear medicine 1985;26 (2):155-156 [PubMed]